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ABSTRACT 
The biosynthesis of value-added products has shown great promise in recent years due to the 
advances in molecular biology and protein engineering.  Many advantages over chemical 
synthesis include high selectivity and specificity, increased yield, and function under milder 
conditions without the need for toxic metals, organic solvents, strong acids or bases, or high 
pressures and temperatures.  However, naturally occurring enzymatic pathways are often times 
not particularly well suited towards obtaining high product yield due to the organism‘s evolution 
not dependent on the production of such high levels of desired product.  Xylitol is an attractive 
pentose sugar alcohol that has many applications in the food, pharmaceutical, and high-value 
based biochemical product industries.  It is still, however, relatively expensive to produce, which 
prevents its economical integration into the marketplace.  To expand the possible routes of 
xylitol synthesis, and provide a process which can utilize both hemicellulosic pentose sugars D-
xylose and L-arabinose from renewable plant biomass as feed substrates, my thesis research 
focused on utilizing a fungal-derived biosynthetic pathway for production of xylitol.  The 
pathway consists of two NADPH-dependent reductases, xylose reductase (XR) and L-xylulose 
reductase (LXR), and an NAD
+
-dependent L-arabinitol 4-dehydrogenase (LAD).  The XR 
enzyme converts D-xylose directly to xylitol, while the three enzyme in tandem convert L-
arabinose to xylitol.  However, the cofactor imbalance presented with the pathway potentially 
makes nicotinamide regeneration difficult for production in vivo.  After cloning and 
characterization of a highly active and stable NAD
+
-dependent L-arabinitol 4-dehydrogenase 
(LAD) from Neurospora crassa, subsequent engineering via rational design and directed 
evolution resulted in the isolation of the first known NADP
+
-dependent LAD enzyme.  This 
novel engineered LAD was then introduced into the fungal xylitol pathway and expressed in a 
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model organism, E. coli, and the effect of the cofactor specificity alteration was evaluated in the 
conversion of L-arabinose to xylitol.  Further investigation of the cofactor balancing benefits 
were applied to xylitol dehydrogenase (XDH) for full redox balancing of the initial steps of the 
L-arabinose pathway, and investigations of the limiting steps in L-arabinose utilization conducted 
in S. cerevisiae and E. coli led to further proposed engineering of LAD. 
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CHAPTER 1 – Biosynthesis of Value-Added Products and Biofuels 
1.1.  Introduction 
Xylitol is a five-carbon sugar alcohol with a growing market as a sweetener that can be produced 
by either chemical or biotechnological methods.  The early research and development work of 
xylitol began in Finland during the 1970‘s, and has been thoroughly reviewed by Mäkinen and 
Peldyak
1
.  In 1974, the Finnish Sugar Company Ltd. began the first large-scale production of 
xylitol in Southern Finland.  In 1975, the first sugar-free dental product was launched through 
the introduction of a xylitol chewing gum (first in Finland, then the United States).  Over the 
next 25 years, global awareness of the significant advantages that xylitol offers to great-tasting 
confectionery and gum products has steadily increased, especially the unique health and dental 
benefits it provides.  When continuously supplied in the diet, xylitol limits the tendency to 
obesity, and its incorporation into food formulations results in improvement of the color and 
taste of preparations without causing undesired changes in properties during storage.  Along with 
fructose, xylitol is the sugar recommended for diabetic patients, due to its human metabolism not 
being insulin-mediated.  In addition, the anticariogenic property of xylitol inhibits the growth of 
oral bacteria so as to reduce plaque formation
2
, and it has also been reported that xylitol helps to 
prevent acute otitis media (ear infection) in small children
3
.  Recently the Department of Energy 
(DOE) reported that xylitol was considered one of the top twelve sugar-derived building blocks 
that can be subsequently converted to a number of high-value bio-based chemicals or materials
4
.  
However, there is currently limited commercial production of xylitol, due mainly in part to its 
comparatively high production cost (about 10 times that of alternatives sucrose or sorbitol) by 
chemical reduction of D-xylose
5
. 
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1.2.  Chemical Synthesis of Xylitol 
Industrially, xylitol is produced by the chemical reduction of pure D-xylose, obtained from 
hardwood hydrolysates, in the presence of a Raney nickel catalyst under high hydrogen 
pressure
6
.  The pure D-xylose is obtained using an industrial scale chromatographic method for 
separating the different wood hemicellulosic sugars developed in Finland, where at the same 
time the beneficial effects of xylitol in preventing dental caries were found.  Pure and defined D-
xylose is the preferred starting material, which is difficult to obtain from the plant biomass.  
Pretreatment and hydrolysis of lignocellulose from biomass yield a multi-component product 
mixture that, in addition to the xylan (or D-xylose) fraction, contains other reducing sugars (such 
as D-glucose from starch, L-arabinose from arabinan, etc.), acids, and various products of 
decomposition of lignin and sugars
7
.  The recovery of xylitol from the xylan fraction is about 
50–60%, or roughly 8–15% of the raw material employed8. The value depends on the xylan 
content of the raw material.  There have been a number of patents filed on methods for obtaining 
pure xylose and production of xylitol from xylan-containing materials
6,9-13
.  Drawbacks of the 
chemical route of synthesis are the requirements of high pressure (up to 50 atm) and temperature 
(80–140 C), use of an expensive catalyst, and use of extensive multi-step separation and 
purification techniques, including mechanical filtration and chromatographic separation, to both 
obtain pure initial D-xylose and to remove the other polyols and by-products after chemical 
reduction. 
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1.3.  Biotechnological Synthesis of Xylitol from Xylose 
1.3.1.  Bacterial Production of Xylitol 
Xylitol has been reported to be produced by bacteria such as Enterobacter liquaefaciens
14
, 
Corynebacterium sp.
15
, and Myobacterium smegmatis
16
. In experiments leading to xylitol 
production, an E. liquaefaciens strain was reported to reach 33.3 g xylitol L
-1
 in a fermentation 
medium containing 100 g initial xylose L
-1
, with a volumetric productivity of 0.35 g L
-1
 h
-1
 
14
.  
Fermentations with M. smegmatis (either as washed cells or as an immobilized form) 
transformed D-xylose to xylitol at the same rate, giving 70% yield, and xylitol production from 
D-xylose using commercial xylose isomerase from Bacillus coagulans and immobilized M. 
smegmatis achieved a yield of 4 g xylitol from 10 g of D-xylose
16
.  Recombinant Lactococcus 
lactis carrying the xylose reductase from Pichia stipitis and the xylose transporter from 
Lactobacillus brevis gave xylitol productivity of 2.72 g L
-1
 h
-1
 during 20 h fermentations
17
.  
Some advantages of using bacterial hosts are a nearly quantitative yield of xylitol from xylose, 
competitive volumetric productivity, and no requirement for aeration.  However, conversions 
typically do no proceed to completion at high initial xylose concentrations, requiring the 
implementation of separation and recycling of D-xylose remaining in the product medium. 
1.3.2.  Fungal Production of Xylitol 
Conversion of D-xylose to xylitol in a fermentation system using a fungal culture Petromyces 
albertensis has been reported.  In culture mediums containing 100 g L
-1
 initial D-xylose, cultures 
reached 39.8 g L
-1
 xylitol after 10 days
18
.  After 160 h of anaerobic fermentation, Fusarium 
oxysporum utilized almost 35 g L
-1
 of xylose and the maximum xylitol concentration (11.5 g L
−1
) 
was observed using ammonium as nitrogen source
19
.  Small concentrations of xylitol have also 
been reported from cultured filamentous fungi including Penicillium, Aspergillus, Rhizopus, 
4 
 
Gliocladium, Byssochlamys, Myrothecium, and Neurospora when grown on D-xylose-based 
media
20
. 
1.3.3.  Yeast Production of Xylitol 
Xylitol can be produced by natural xylose-assimilating yeasts, and varies a great deal with 
species and aeration conditions.  A wide range of yeast species belonging to the genus Candida 
are well-known for their potential industrial applications, and include Candida tropicalis
21-25
, 
Candida guilliermondii
26
, Candida boidinii
27,28
, Candida parapsilosis
29
, Candida maltosa
30
, and 
Candida peltata
31,32
..  Candida tropicalis produced 8.5 g L
−1
 h
−1
 xylitol from D-xylose (yield of 
0.85 mol mol
-1
 D-xylose, final concentration 180 g L
-1
 xylitol) in a cell recycling process in a 
submerged membrane bioreactor with suction pressure and air sparging
23
.  When attempting to 
ferment the processed hydrolysate without the added step of purifying substrate D-xylose, C. 
tropicalis xylitol production was found to be 0.43 g/g and 0.45 g/g of D-xylose utilized with corn 
fiber and sugarcane bagasse hydrolysate respectively, and after strain improvement by sub-
culturing, the production jumped to levels of 0.58 g/g and 0.65 g/g of D-xylose with corn fiber 
hydrolysate and sugarcane bagasse hydrolysate respectively
33
.  The productivity for an 
engineered C. tropicalis with an integrated NADH-preferring XR from Candida parapsilosis 
was 5.1 g L
-1 
h
-1 34
.  Debaryomyces hansenii (Candida famata) produced 4.6 g L
−1
 h
−1
 xylitol 
with a xylitol yield of 0.78 mol mol
−1
 from D-xylose and a final xylitol concentration of 221 g L
-1 
35
.  The ability of Candida peltata to ferment D-xylose to xylitol was evaluated and a maximum 
xylitol yield of 0.56 g g
-1
 D-xylose was obtained when the yeast was cultivated in optimized 
conditions.  The yeast also produced ethanol (0.41 g g
-1
 in 40 h) from glucose (50 g L
-1
) and 
arabinitol (0.55 g g
-1
 in 87 h) from L-arabinose (50 g L
-1
).  Interestingly, moderate levels of 
glucose (10 g L
-1
), ethanol (7.5 g L
-1
) and acetate (5 g L
-1
) inhibited xylitol production by 61, 84 
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and 68%, respectively, whereas L-arabinose (10 g L
-1
) had no inhibitory effect on xylitol 
production
31
.  Another reoccurring phenomenon in most fermentation experiments was that 
yeasts preferentially utilize glucose > D-xylose > L-arabinose from mixed substrates. 
Xylitol production from D-glucose was also demonstrated using S. cerevisiae
36
.  A transketolase-
deficient strain (W303-1B tlk1 tlk2) growing on glucose accumulated D-xylulose 5-phosphate 
intracellularly and released ribitol and pentose sugars D-ribose, D-ribulose, and D-xylulose into 
the growth medium.  Over-expressing the xylitol dehydrogenase from P. stipitis, which catalyzes 
the reduction of D-xylulose to xylitol, and deletion of the xylulokinase-encoding gene (XKS1) 
resulted in the production of xylitol and ribitol from D-xylulose and D-ribulose, respectively.  
The yield of xylitol and ribitol formation was considerably lower than other methods, although 
the authors did not attempt to optimize production conditions or metabolically engineer their 
strain for improved PPP capacity. 
1.4.  L-Arabinose as a Substrate for Xylitol Production 
Hemicellulose is the second most common polysaccharide in nature, representing 20-40% of 
lignocellulosic (plant material) biomass.  Hemicelluloses are heterogeneous polymers comprised 
mostly of pentoses (D-xylose, L-arabinose), with minor contributions from hexoses (mannose, 
glucose, galactose), and sugar acids
37
.  The utilization of the hemicellulose fraction for xylitol 
production has been the subject of numerous research papers and patents
9,33,37-41
, but only the D-
xylose component is converted to xylitol, with the other major component of hemicellulose, L-
arabinose, being converted to undesired byproduct L-arabinitol.  However, D-xylose and L-
arabinose metabolism in yeasts and filamentous fungi conveniently share xylitol as an 
intermediate (Figure 1.1).  If the L-arabinose component of hemicellulose could also be utilized 
for xylitol production, the economic feasibility by fermentative means could increase 
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dramatically.  However, L-arabinose utilization by yeasts and filamentous fungi is poorly 
characterized to date
42
, and strains that do utilize L-arabinose typically produce large amounts of 
L-arabinitol, instead of xylitol, along with biomass, suggesting a limitation earlier in the 
utilization pathway
43
. 
One major issue that has yet to be resolved in utilization of L-arabinose as a substrate for xylitol 
or ethanol is the subject of redox cofactor imbalance.  The fungal pathway consists of two 
oxidations and two reductions, which is redox neutral.  However, the oxidations are NAD(H)-
linked and the reductions are NADP(H)-linked, so that there is an imbalance of the cofactors 
involved in the process.  In the view of xylitol production, the imbalance cannot be properly 
regenerated by the cell‘s metabolism, leading to accumulation of L-arabinitol, the product of the 
first enzyme in the pathway.  In the view of fermentation, it remains an open question how 
fungal micro-organisms cope with this cofactor imbalance.  It has been suggested that NADPH is 
mainly regenerated through the oxidative part of the pentose phosphate pathway
44
. The 
filamentous fungus Aspergillus niger exhibited higher activities of glucose 6-phosphate 
dehydrogenase and 6-phosphogluconate dehydrogenase when growing on pentoses
44
. In the 
oxidative part of the pentose phosphate pathway, however, the reduction of NADP
+
 is coupled to 
CO2 production.  In this case the anaerobic conversion of L-arabinose to CO2 and ethanol is no 
longer redox neutral, i.e. the fermentation of L-arabinose is inhibited by an accumulation of 
reduced redox cofactors.  Some attempts at engineering cofactor regeneration into these 
processes have met with limited success, and those pertaining to xylose utilization are mentioned 
below. 
One proposed strategy of dealing with the cofactor imbalance was to integrate transhydrogenase 
activity to facilitate the equilibrium between the coenzymes involved.  Transhydrogenases 
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catalyze the reduction of NADP
+
 to NADPH with concomitant oxidation of NADH to NAD
+
.  
Yeasts are not believed to have such endogenous activity
45
, so the expression of a cytosolic 
transhydrogenase gene from Azotobacter yinlandii in S. cerevisiae was attempted and the 
intracellular concentrations of the NAD(P) and NAD(P)H cofactors were measured
46
.  It was 
hypothesized that since NADH could be consumed and NADPH produced by the enzyme, 
expression of the gene encoding transhydrogenase could result in a decrease in glycerol 
formation and the carbon flux through the pentose phosphate pathway, where there is a loss of 
carbon in the form of carbon dioxide.  This reduction in the carbon flux towards waste  
components could be redirected towards formation of ethanol, leading to higher yield.  However, 
this was not found to be the case, as there was a resulting decrease in ethanol production and 
increase in production of 2-oxogluarate and glycerol.  Unfortunately, no mention was made of 
the effects on pentose consumption or xylitol production. 
Another strategy was to induce changes in the pentose phosphate pathway itself in order to try 
and uncouple NADPH regeneration and CO2 production.  In one study, the disruption of the 
GND1 gene, one of the isogenes of 6-phosphogluconate dehydrogenase, or disruption of the 
ZWF1 gene, which encodes glucose 6-phosphate dehydrogenase, blocked the pentose phosphate 
pathway.  These modifications resulted in a lower xylitol yield and higher ethanol yield than in 
control strains.  Also, xylitol production was shown to be strongly connected to the flux through 
the oxidative part of the pentose phosphate pathway using metabolic flux analysis
47
.  A follow-
up to this approach expressed GDP1, which encodes for a fungal NADP
+
-dependent D-
glyceraldehyde-3-phosphate dehydrogenase (NADP-GAPDH), in a ZWF1 S. cerevisiae strain, 
resulting in further stimulated xylose fermentation with respect to rate and yield, with increased 
ethanol production under anaerobic conditions
48
. 
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There was a recent publication during the course of the present thesis preparation by Bettiga et 
al.
49
 that attempted at resolving the redox balance for L-arabinose utilization, which sought to 
introduce a pathway that depends solely on NAD(H) using an engineered NADH-preferring 
xylose reductase and a native NADH-preferring L-xylulose reductase along with NAD
+
-
dependent dehydrogenases for a cofactor balanced pathway.  While the authors were focused on 
improving pentose fermentation to ethanol, the attempt at improving the flux past L-arabinitol 
using a cofactor-balancing strategy was shown to be effective, and will be discussed in Chapter 
5.  The goal of my work was to engineer NADP
+
-dependent L-arabinose pathway 
dehydrogenases by means of rational design and directed evolution for application in xylitol or 
biofuel production from hemicellulosic pentose sugars. 
1.5. Protein Engineering 
The tailoring of enzymes can be accomplished through two experimental routes.  The first is 
rational design, which targets specific residues of a protein for mutagenesis to predetermined 
amino acid mutations, and is only applicable when there is detailed knowledge of the 
relationships between the enzyme‘s structure and mechanism/function.  And while an increasing 
number of enzymes are being characterized, the majority do not have this depth of information 
readily available, as it requires considerable effort to obtain.  In the absence of this information, 
the tailoring of an enzyme can still be accomplished through the second route - directed 
evolution. 
Directed evolution is the general term applied to the combined techniques of generation of a 
library of protein mutants (or variants) and selection of a protein with desirable function from 
within that library
50
.  It is an iterative Darwinian optimization process, whereby the fittest 
variants are selected from an ensemble of mutants
51
.  Directed evolution can be used to target a 
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number of enzymatic characteristics, including activity, substrate specificity, thermal and 
oxidative stability, enantioselectivity or enantiospecificity, pH optima or range, and tolerance to 
solvent
52
.  While a typical directed evolution experiment focuses on a single enzymatic trait, 
there are some examples of improving several traits simultaneously. 
Choosing the appropriate methods of library generation and screening or selection is paramount 
to the success of any directed evolution experiment.  Library diversity can be created through 
either mutagenesis (random or semi-rational) or gene recombination, and which of these methods 
is chosen depends on many factors, such as the availabilities of homologous genes, structural 
knowledge, and characteristic data of the enzyme of interest.  The library size created is typically 
very large (>10
4-6
), and close evaluation of each variant is not feasible.  The need for a method to 
find the improved ―needle in a haystack‖ enzyme becomes evident, with several strategies 
including selection, enrichment, and high-throughput screening offering ways to sift through the 
library clutter and find a variant with the desired enzymatic trait.  However, once an evolved 
enzyme has been found that exhibits improved characteristics, the artificial conditions in which 
the selection method was carried out may result in an enzyme whose properties may not carry 
over to the real biocatalytic process.  Therefore, the more similar a screening system is to the 
actual application process, the more likely it is to find an improved enzyme that will be 
complementary to the application. 
1.6.  Project Overview 
My research focused on two main projects: the engineering of an NADP
+
-dependent L-arabinitol 
4-dehydrogenase and its application in xylitol biosynthesis from pentose sugars L-arabinose and 
D-xylose, and engineering a cofactor balanced fungal L-arabinose pathway and analyzing its 
effects on biofuel production.  The first project focuses on the utilization of protein engineering 
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tools of rational and semi-rational design combined with directed evolution to reverse the 
cofactor specificity of a single enzyme of a three-enzyme pathway in an attempt to improve flux 
from L-arabinose substrate to product xylitol.  The effect of this cofactor balancing is 
investigated in a model organism, E. coli, and shown to enhance xylitol production from L-
arabinose and D-xylose.  The engineering of an NADP
+
-dependent xylitol dehydrogenase and 
introduction of the full L-arabinose assimilation pathway is established, with investigation into 
the limiting factors of growth complementation in S. cerevisiae and E. coli when using the 
cofactor dependent fungal pathway, with insights leading to further projects past the scope of this 
thesis. 
Chapter 2 describes the cloning and characterization of a novel L-arabinitol 4-dehydrogenase 
(LAD) from Neurospora crassa, which is one of the most active and stable LADs reported.  
Similar to all other characterized LADs, the enzyme is strictly NAD
+
-dependent.  The high 
stability is attributed to the structural zinc ion, and the substrate specificity of the LAD is 
analyzed further by mutational analysis by comparison of active site residues to homologous 
xylitol and sorbitol dehydrogenases.  The enzyme is highly active and stable, acts on several five 
carbon sugar alcohol substrates, and operates over a wide pH range, although the activity in 
acidic pHs drops considerably, which is an issue that is addressed in its usage in the xylitol 
production strategy in Chapter 4. 
Chapter 3 describes the application of rational and semi-rational design followed by directed 
evolution to reverse the cofactor specificity of L-arabinitol 4-dehydrogenase from NAD
+
 to 
NADP
+
.  Using the engineered enzyme along with NADPH-dependent xylose reductase and L-
xylulose reductase was hypothesized to alleviate the cofactor imbalance of the pathway such that 
conversion of L-arabinose and/or D-xylose to xylitol along with a cosubstrate would produce 
11 
 
more desired product xylitol than the wild-type pathway.  By using bioinformatics tools for 
BLAST search and sequence alignment, along with homology modeling of the enzyme of 
interest, key residues involved in the cofactor specificity were identified and subjected to site-
directed mutagenesis and saturation mutagenesis and screened for improved NADP
+
 activity.  
When rational design sites were exhausted, the enzyme kinetics were further improved by 
implementation of a directed evolution strategy following the validation of a proper screening 
procedure.  This resulted in the first known NADP
+
-dependent LAD enzyme. 
Chapter 4 describes the application of expressing xylose reductase, wild-type or engineered L-
arabinitol 4-dehydrogenase, and L-xylulose reductase for xylitol biosynthesis from L-arabinose 
and D-xylose.  The effects of pH-control as well as substrate sugar ratios are also addressed. 
Chapter 5 describes the cloning, characterization of xylitol dehydrogenase (XDH) from N. 
crassa, and the engineering of an NADP
+
-dependent XDH by rational design.  With the 
engineered LAD created in Chapter 4, the cofactor imbalance associated with the reductases and 
dehydrogenases of the initial L-arabinose pathway is relieved, and the subsequent introduction of 
the pathway into S. cerevisiae and E. coli paves the way for investigation into the limiting factors 
of L-arabinose utilization with the fungal-based pathway. 
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CHAPTER 2 – Cloning, Expression, Purification, and Characterization of 
L-Arabinitol 4-Dehydrogenase from Neurospora crassa 
2.1. Introduction 
As detailed in Chapter 1, the route through which L-arabinose is converted to xylitol in the 
fungal pathway passes through three key enzymes: xylose reductase (XR), L-arabinitol 4-
dehydrogenase (LAD), and L-xylulose reductase (LXR).  There are many examples of XRs that 
have been characterized from various source organisms, including a highly active XR 
characterized by Ryan Woodyer and Michael Simurdiak in Professor Zhao‘s laboratory from 
Neurospora crassa, a filamentous fungus known to ferment xylose
1
.  With the first enzyme of 
the process already available, the focus turned to the remaining two enzymes that would 
complete the process.  However, there are relatively few cases of the other two enzymes being 
isolated and identified.  The cloning and characterization of the LXR from N. crassa was done 
by Nikhil Nair in the Zhao laboratory.  However, this enzyme did not possess high affinity 
towards substrate L-xylulose, with an unusually high Km,L-xylulose value of > 275 mM.  It was also 
recently challenged that the homologous LXR1 from Hypocrea jecorina was instead a D-
mannitol 2-dehydrogenase (MDH) based on phylogenetic analysis and deletion experiments 
showing deletion of lxr1 did not affect growth on L-arabinose, whereas MDH activity levels 
dropped
2
.  Due to the inconclusive identity of N. crassa LXR and less than desirable kinetic 
parameters, the reported LXR from Aspergillus niger was selected for the xylitol production 
process due to its higher affinity towards L-xylulose (Km,L-xylulose of 17 mM)
3
. 
The final enzyme remaining, L-arabinitol 4-dehydrogenase (LAD, EC 1.1.1.12), is commonly 
found in yeasts and filamentous fungi and catalyzes the second step of the fungal L-arabinose 
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metabolic pathway by oxidizing L-arabinitol to L-xylulose with concomitant NAD
+
 reduction.  
LAD is purportedly a fungal orthologue of the eukaryotic sorbitol dehydrogenase (SDH)
4
 and 
belongs to the family of zinc-containing alcohol dehydrogenases.  Several LADs have 
successfully been cloned and expressed
3,5,6
.  However, they are not optimal for in vivo enzymatic 
production of xylitol due to their poor stability and/or activity.  This chapter will focus on the 
cloning, expression, purification, and characterization of a novel LAD from N. crassa with high 
activity and stability for use in xylitol production from L-arabinose and D-xylose.  This enzyme 
serves as the template for engineering altered coenzyme specificity that will be detailed further in 
Chapter 3. 
2.2. Results 
2.2.1. N. crassa LAD Gene Identification 
LADs from Hypocrea jecorina (GenBank accession number AF355628.1) and Aspergillus 
oryzae (AB116938.2) were used as templates for a protein BLAST search 
(www.ncbi.nlm.nih.gov).  Utilizing the whole-genome sequence of N. crassa
7
, a postulated 
LAD-encoding gene, hypothetical protein NCU00643.1 (EAA36547.1), was discovered which 
had the greatest sequence identity (~80%).  This protein (referred to as N. crassa LAD hereafter) 
had significant homology (72 to 80% identity) with other LADs (Fig. 2.1).  Among the 
conserved residues were those that formed the active site and the structural Zn
2+
-binding site
8
 
and the glycine fingerprint
9
 found in polyol dehydrogenases, as well as the majority of those 
shown to bind substrate in the SDH homologues
4
. 
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Neurospora crassa                 MASSAS-------------KTNIGVFTNPQHDLWISEASPSLESVQKGEE 
Hypocrea jecorina                 MSPSAVDDAPKATGAAISVKPNIGVFTNPKHDLWISEAEPSADAVKSGAD 
Aspergillus niger                 MATATVLE-----------KANIGVFTNTKHDLWVADAKPTLEEVKNGQG 
Aspergillus oryzae                MATATVLE-----------KANIGVYTNTNHDLWVAESKPTLEEVKSGES 
Aspergillus fumigatus             MATATTTVLE---------KPNIGVYTNPKHDLWIAESTPTLEDVKSGNG 
                                   :.::              *.****:**.:****:::: *: : *:.* 
 
Neurospora crassa                 LKEGEVTVAVRSTGICGSDVHFWKHGCIGPMIVECDHVLGHESAGEVIAV 
Hypocrea jecorina                 LKPGEVTIAVRSTGICGSDVHFWHAGCIGPMIVEGDHILGHESAGEVIAV 
Aspergillus niger                 LQPGEVTIEVRSTGICGSDVHFWHAGCIGPMIVTGDHILGHESAGQVVAV 
Aspergillus oryzae                LKPGEVTVQVRSTGICGSDVHFWHAGCIGPMIVTGDHILGHESAGEVIAV 
Aspergillus fumigatus             LKPGEVTIEVRSTGICGSDVHFWHAGCIGPMIVEGDHILGHESAGQVIAV 
                                  *: ****: **************: ********  **:*******:*:** 
 
Neurospora crassa                 HPSVKSIKVGDRVAIEPQVICNACEPCLTGRYNGCERVDFLSTPPVPGLL 
Hypocrea jecorina                 HPTVSSLQIGDRVAIEPNIICNACEPCLTGRYNGCEKVEFLSTPPVPGLL 
Aspergillus niger                 APDVTSLKPGDRVAVEPNIICNACEPCLTGRYNGCENVQFLSTPPVDGLL 
Aspergillus oryzae                ASDVTHLKPGDRVAVEPNIPCHACEPCLTGRYNGCEKVLFLSTPPVDGLL 
Aspergillus fumigatus             APDVTSLKPGDRVAIEPNIPCHACEPCLTGRYNGCLNVAFLSTPPVDGLL 
                                   . *. :: *****:**:: *:************* .* ******* *** 
 
Neurospora crassa                 RRYVNHPAVWCHKIGNMSYENGAMLEPLSVALAGLQRAGVRLGDPVLICG 
Hypocrea jecorina                 RRYVNHPAVWCHKIGNMSWENGALLEPLSVALAGMQRAKVQLGDPVLVCG 
Aspergillus niger                 RRYVNHPAIWCHKIGDMSYEDGALLEPLSVSLAGIERSGLRLGDPCLVTG 
Aspergillus oryzae                RRYVNHPAVWCHKIGDMSYEDGALLEPLSVSLAAIERSGLRLGDPVLVTG 
Aspergillus fumigatus             RRYVNHPAVWCHKIGDMSFEDGALLEPLSVSLAAIERSGLRLGDPCLITG 
                                  ********:******:**:*:**:******:**.::*: ::**** *: * 
 
Neurospora crassa                 AGPIGLITMLCAKAAGACPLVITDIDEGRLKFAKEICPEVVTHKVER-LS 
Hypocrea jecorina                 AGPIGLVSMLCAAAAGACPLVITDISESRLAFAKEICPRVTTHRIEIGKS 
Aspergillus niger                 AGPIGLITLLSARAAGASPIVITDIDEGRLEFAKSLVPDVRTYKVQIGLS 
Aspergillus oryzae                AGPIGLITLLSARAAGATPIVITDIDEGRLAFAKSLVPDVITYKVQTNLS 
Aspergillus fumigatus             AGPIGLITLLSAKAAGATPLVITDIDEGRLQFAKSLVPEVRTYKVQFGLS 
                                  ******:::*.* **** *:*****.*.** ***.: * * *::::   * 
 
Neurospora crassa                 AEESAKKIVESFG--------GIEPAVALECTGVESSIAAAIWAVKFGGK 
Hypocrea jecorina                 AEETAKSIVSSFG--------GVEPAVTLECTGVESSIAAAIWASKFGGK 
Aspergillus niger                 AEQNAEGIINVFNDGQGSGPGALRPRIAMECTGVESSVASAIWSVKFGGK 
Aspergillus oryzae                AEDNAAGIIDAFNDGQGSAPDALKPKLALECTGVESSVASAIWSVKFGGK 
Aspergillus fumigatus             AEEQANAIINVFNDGQGSGPDALRPRLALECTGVESSVASAIWSVKFGGK 
                                  **: *  *:. *.        .:.* :::********:*:***: ***** 
 
Neurospora crassa                 VFVIGVGKNEIQIPFMRASVREVDLQFQYRYCNTWPRAIRLVENGLVDLT 
Hypocrea jecorina                 VFVIGVGKNEISIPFMRASVREVDIQLQYRYSNTWPRAIRLIESGVIDLS 
Aspergillus niger                 VFVIGVGKNEMTVPFMRLSTWEIDLQYQYRYCNTWPRAIRLVRNGVIDLK 
Aspergillus oryzae                VFVIGVGKNEMKIPFMRLSTQEIDLQYQYRYCNTWPRAIRLVRNGVISLK 
Aspergillus fumigatus             VFVIGVGKNEMTIPFMRLSTQEIDLQYQYRYCNTWPRAIRLVQNGVINLK 
                                  **********: :**** *. *:*:* ****.*********:..*::.*. 
 
Neurospora crassa                 RLVTHRFPLEDALKAFETASDPKTGAIKVQIQSLE------------ 
Hypocrea jecorina                 KFVTHRFPLEDAVKAFETSADPKSGAIKVMIQSLD------------ 
Aspergillus niger                 KLVTHRFLLEDAIKAFETAANPKTGAIKVQIMSSEDDVKAASAGQKI 
Aspergillus oryzae                KLVTHRFLLEDALKAFETAADPKTGAIKVQIMSNEEDVKGASA---- 
Aspergillus fumigatus             RLVTHRFALEDALKAFETAANPKTGAIKVQIMSSEEDVKAASATQ-- 
                                  ::***** ****:*****:::**:***** * * :             
 
Figure 2.1.  Protein sequence alignment of N. crassa LAD with four other closely related LAD 
sequences from filamentous fungi and yeast.  Residues highlighted in gray represent the four 
conserved residues that make up the catalytic zinc binding tetrad. Residues highlighted in red 
represent the four conserved cysteine residues that make up the proposed structural zinc binding 
tetrad. 
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2.2.2. Cloning, Expression, and Purification of N. crassa LAD 
RT-PCR performed on total RNA isolated from L-arabinose-induced N. crassa 10333 showed 
the expected size of gene product (~1.1 kb).  The RT-PCR product was cloned into the pGEX-
4T-3 vector using EcoRI and NotI restriction sites and was transformed into E. coli BL21 (DE3).  
This construct (pGEX-lad1) expressed N. crassa LAD as an N-terminal GST-tagged fusion with 
a thrombin cleavage site.  Cell lysates of IPTG-induced cultures of these cells were prepared, 
analyzed by SDS-PAGE, and assayed for LAD activities.  The construct produced soluble GST-
tagged N. crassa LAD at ~16% of the total soluble cellular proteins (Fig. 2.2), which was then 
purified in a single step with a GST-Bind kit according to manufacturer‘s protocol.  The purified 
protein was desalted by ultrafiltration with several washes of 50 mM morpholinepropanesulfonic 
(MOPS) buffer (pH 7.25).  After digesting with biotinylated thrombin, the enzyme was incubated 
with streptavidin agarose to remove the thrombin and then passed through GST-Bind resin again 
to remove the cleaved GST-tag.  GST-tagged LAD cleaved with thrombin was used for 
characterization purposes, as it had about 65% greater specific activity than the tagged LAD 
enzyme.  LAD stocks were stored frozen with 10% (v/v) glycerol at −80 °C.  Protein 
concentrations were determined by the Bradford method
10
 by using an estimated extinction 
coefficient (San Diego Supercomputer Center Biology Workbench [http://workbench.sdsc.edu]) 
of 35.3 mM
−1
 cm
−1
 at 280 nm with similar results.  The purity of the protein was analyzed by an 
SDS-PAGE gel stained with Coomassie brilliant blue (Fig. 2.2).  The final yield of protein was 
30 mg/L of culture (~9 mg/g of E. coli) of greater than 95% pure LAD with a molecular mass of 
~39 kDa, consistent with the predicted value of 39.6 kDa. 
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Figure 2.2. Overexpression and purification of recombinant N. crassa LAD.  Lane 1, the 
molecular weight marker proteins (size in kDa is shown); lane 2, cell-free crude extract; lane 3, 
purified LAD enzyme with N-terminal GST-tag; lane 4, purified LAD enzyme with GST-tag 
removed by thrombin cleavage. 
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2.2.3. Steady-state Kinetics 
Purified N. crassa LAD displayed activity with NAD
+
 as the preferred cofactor (Table 2.1), 
although there was small yet detectable activity with NADP
+
, which was verified later by high 
performance liquid chromatography (HPLC) as shown in Figure 2.5.  This is the first reported 
detection of NADP
+
 utilization by an LAD, although it is still considered a strongly NAD
+
-
dependent enzyme. 
Table 2.2 displays the kinetic constants of several other sugar substrates accepted by N. crassa 
LAD. D-Arabinitol, adonitol, xylitol, D-sorbitol, and D-mannitol were all examined as alternative 
substrates for N. crassa LAD with NAD
+
 as the cofactor.  Of those, only the five carbon sugar 
alcohols acted as substrates, with Km values of 80 mM and 280 mM for adonitol and xylitol, 
respectively.  This pattern of substrate promiscuity is similar to those of LADs isolated from 
other sources
5,6
.  Kinetic parameters of characterized LADs from Hypocrea jecorina, Aspergillus 
niger, and Aspergillus oryzae are displayed in Table 2.3
3-6
. 
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TABLE 2.1.  Kinetic parameters for N. crassa LAD
a
. 
N. crassa LAD with 
indicated coenzyme 
Km for NAD(P)
 
(mean  SD) (M) 
kcat (mean  SD) 
(min
-1
) 
kcat/Km for NAD(P) 
(M-1 min-1) 
Km for L-arabinitol
 
(mean  SD) (mM) 
NAD 174  24 1,206  54 6.9 16  3 
NADP - - 4.3 x 10
-5
 - 
 
a
 All assays were performed at 25 C in 50 mM Tris, pH 8.0 
 
TABLE 2.2.  Kinetic parameters for N. crassa LAD with other substrates
a
. 
N. crassa LAD with 
indicated substrate 
kcat (mean  SD) 
(min
-1
) 
Km (mean  SD) 
(mM) 
kcat/Km 
(mM
-1
 min
-1
) 
% Activity 
   L-Arabinitol      1,210  30         18  2 67       100 
      Xylitol         970  40       290  27      3.3           4.9 
      Adonitol      1,080  30         35  3 31         46 
   D-Arabinitol - - ND
b
           0 
   D-Sorbitol -
c
 -
c
    -
c
           0
c
 
   D-Mannitol - - ND           0 
 
a
 All assays were performed at 25C in 50 mM Tris, pH 8.0, at saturated NAD+ 
concentration 
b
 ND, not detected 
c
 trace activity at 2 M D-sorbitol concentration, possibly due to substrate contamination 
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TABLE 2.3.  Kinetic parameters of LAD from various source organisms. 
Organism (reference) 
Specific activity 
(U/mg) 
kcat 
(min
-1
) 
Km, L-arabinitol 
(mM) 
kcat/Km, L-arabinitol 
(mM
-1
 min
-1
) 
Km, NAD+ 
(M) 
N. crassa (this work) 31 1,206 16 75 174 
H. jecorina 
5
      1.6  N/Aa 40 N/A 180 
H. jecorina 
4
          0.013    51     4.5 11 N/A 
A. niger 
3
 96 N/A 89 N/A  50 
A. oryzae 
6
       0.04 N/A N/A N/A N/A 
a 
N/A, not determined 
 
TABLE 2.4.  Kinetic parameters of F59 mutants
a
. 
Substrate Enzyme 
kcat (mean  SD) 
(min
-1
) 
Km (mean  SD) 
(mM) 
kcat/Km 
(mM
-1
 min
-1
) 
L-Arabinitol WT      1,210  30         18  2 67 
 F59Y         840  30         42  5               20 
 F59S           60  3         62  9                 0.97 
 F59A -
b
    > 400                 0.12 
Xylitol WT         970  40       290  27      3.3 
 F59Y -
 b
    > 880                 1.2 
 F59S -
 b
 > 1,400                 0.04 
 F59A -
 b
 > 1,850                 0.01 
Adonitol WT      1,080  30         35  3 31 
 F59Y      1,420  50       193  11                   7.4 
 F59S         120  5       430  48                 0.28 
 F59A -
 b
 > 1,110                 0.03 
 
a
 All assays were performed at 25 C in 50 mM Tris, pH 8.0. 
b
 Saturation of substrate was not reached. 
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2.2.4. Temperature and pH Dependence 
The data show the optimum temperature to be between 45 and 55 °C (Fig. 2.3A).  At higher 
temperatures, the enzyme inactivates rapidly, and at lowered temperatures, the rate increases 
with temperature according to the Arrhenius equation.  Utilizing the Arrhenius equation to fit the 
data from 12 to 30 °C, the energy of activation for L-arabinitol oxidation by N. crassa LAD was 
determined to be 47 kJ/mol.  The stability for N. crassa LAD was relatively high, as it retained 
activity at room temperature for longer than one month and at 4 °C for several months.  Figure 
2.3B shows the results of thermal inactivation of N. crassa LAD at 50 °C, which followed a first-
order exponential decay with a half-life of 36 min.  Interestingly, when tested at a slightly lower 
temperature of 45 °C, the enzyme was able to retain ~70% of its activity after 3 hr.  The high 
stability can potentially be attributed to the conserved structural zinc binding residues. A similar 
thermostabilizing mechanism was also found in alcohol dehydrogenase
11
 and engineered xylitol 
dehydrogenase
12
. 
The pH range for N. crassa LAD activity was large, with >25% of the activity occurring with pH 
values of 7.0 to 10.5 (Fig. 2.3C).  The pH optimum was around pH 9.5, and >60% of the activity 
remained in the 2 pH-unit span from 8.0 to 10.0. 
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Figure 2.3. A) kcat dependence on temperature. N. crassa LAD was assayed at different 
temperatures from 12 to 65 °C at saturating concentrations of 200 mM L-arabinitol and 2 mM 
NAD
+
.  B) Thermal inactivation of LAD at 50 °C. The heat inactivation at 50 °C was irreversible 
and followed first-order kinetics with a half-life of 45 min.  C) pH rate profile.  Saturating 
concentrations of 200 mM L-arabinitol and 2 mM NAD
+
 were used to measure the activity in a 
universal buffer at various pH values from 7.0 to 11.0. 
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2.2.5. Determination of Protein Mass and Quaternary Structure 
Based on the standardized retention times of a Bio-Rad molecular mass standard, the molecular 
mass of the native N. crassa LAD was calculated from its retention time to be ~129 kDa (Fig. 
2.4).  Monomerization was induced in the presence of 15% SDS, causing N. crassa LAD to elute 
as a single peak with a retention time corresponding to a molecular mass of ~39 kDa.  The data 
suggest that the native LAD is a noncovalently linked tetramer, which is typical for fungal 
derived zinc-containing alcohol dehydrogenases
13
. 
 
Figure 2.4. HPLC size exclusion chromatography.  A size exclusion standard was used to 
calibrate a Bio-Sil SEC-250, 300 x 7.8 mm column with a mobile phase of 0.1 M Na2HPO4, 0.15 
M NaCl, 0.01 M NaN3, pH 6.8 at a flow rate of 1 ml/min.  The standard proteins are represented 
by closed squares.  LAD samples (represented by open squares) with and without 15% SDS were 
injected separately and fitted to the standard curve. 
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2.2.6. Cofactor Specificity 
The cofactor specificity of N. crassa LAD was examined by HPLC.  The separation of NAD
+
, 
NADP
+
, NADH, and NADPH (Figs. 2.5A and 2.5B) was carried out as previously described
14
.  
No discernible cross-contamination of oxidized cofactors was observed (data not shown).  20 L 
reaction mixtures consisting of equal parts of 1 mM NAD(P)
+
 and 25 mM L-arabinitol in 50 mM 
Tris-HCl (pH 8.0) were set up, and following addition of approximately 1 g of enzyme, the 
reaction was allowed to proceed for 20 min at 37 °C.  When NAD
+
 was used as the cofactor, the 
products were analyzed by HPLC, and a single peak (UV 340 nm) was observed that had the 
same retention time as authentic NADH (Fig. 2.5C).  The same process was carried out for 
NADP
+
 as the cofactor, and a small yet detectable peak was observed with a retention time 
corresponding to an authentic sample of NADPH (Fig. 2.5D).  This indicated the strong 
preference for NAD
+
 as the cofactor of N. crassa LAD. 
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Figure 2.5.  HPLC analysis of the reaction products of N. crassa LAD.  A) Cofactor stocks, 260 
nm; B) Cofactor stocks, 340 nm; C) NAD
+
 reaction mix products, 340 nm; D) NADP
+
 reaction 
mix before (gray) and after (black) LAD enzyme addition, 340 nm (zoomed in). 
 
2.2.7. Homology Modeling 
The structural model of N. crassa LAD was verified for consistency with known protein folds 
and allowed ϕ and ψ angles.  The Profiles3-D check resulted in a self-compatibility score of 
139.94, which compares well to the scores of 150.53 and 145.49 for the coordinates from 1PL8 
and 1E3J, respectively.  The ProStat check of ϕ and ψ angles were determined to be 81.2% 
within their core expected values, comparing well to the 83.3 and 82.4% for the same analysis of 
PDB structures 1PL8 and 1E3J, respectively.  This model was very similar to the human SDH 
crystal structure in overall fold and binding of coenzyme.  The only major deviation between the 
backbone of these two structures is the N-terminal region of amino acids 1 through 8.  However, 
31 
 
this may be due to the different conformations of the N-terminus between being in solution and 
forming dimerization contacts found to be present in SDH
4
.  The conserved catalytic zinc 
binding residues C53, H78, E79, and E163 have similar orientations and locations in the N. 
crassa LAD model (Fig. 2.6).  When comparing proposed substrate binding residues from SDH 
to N. crassa LAD, the majority—S55, F127, T130, E163, R308, Y309—are strictly conserved 
and configured in similar orientations.  However, one substrate-binding residue, F59, was 
different from the homologous tyrosine residue in SDH, making the N. crassa LAD-binding 
pocket slightly more hydrophobic (Fig 2.6B). 
 
 
 
 
 
 
 
Figure 2.6. A) Homology model of N. crassa LAD with bound NAD
+
 and catalytic zinc ion, 
built using the Insight II and MOE programs.  The catalytic zinc ion (Zn
2+
), four catalytic zinc 
binding residues, and NAD
+
 cofactor are colored by atom type.  B) Active site of N. crassa LAD 
with docked catalytic zinc (shown in space-fill), cofactor NAD
+
, and substrate L-arabinitol 
(colored green) coordinated with the active zinc.  Key residues located within the substrate 
binding pocket are labeled. 
B 
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Y309 
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NAD+ 
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Zn 
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E163 
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2.2.8. F59 Mutational Analysis  
Enzyme activity assays were carried out for three mutants of N. crassa LAD (F59A, F59S, and 
F59Y) to study the effect of mutation of this active site, putative substrate-binding residue 
homologous to tyrosine in other SDHs. All assays were carried out similar to substrate 
specificity profile for the wild-type enzyme (see ―Steady-state kinetics‖ in ―Materials and 
Methods‖), with the cofactor NAD+ held at saturating concentration of 2 mM for all assays. The 
mutants were still found to have activity with L-arabinitol, xylitol, and adonitol, and their kinetic 
parameters are displayed in Table 2.4. D-Sorbitol was also tested but showed no significant 
activity over the wild-type N. crassa LAD. 
2.3. Discussion 
Hypothetical protein NCU00643.1 (EAA36547.1) from N. crassa was found to encode an LAD 
of 363 amino acid residues with a calculated Mr of 39,245.  Sequence alignment with other 
reported LADs shows high homology (~70–80%), with conserved regions for Zn2+-binding, 
cofactor binding, and active site residues.  Comparison with several mammalian SDHs (mouse, 
rat, bovine, sheep, and human) showed ~40% sequence identity, whereas comparison with 
xylitol dehydrogenases (Hypocrea jecorina, Aspergillus oryzae, Candida tropicalis, Pichia 
stipitis, and Aspergillus fumigatus Af293) was ~30% sequence identity. 
Kinetic parameters of characterized LADs from H. jecorina, Aspergillus niger, and A. oryzae are 
displayed in Table 2.3.  It should be noted that only the LAD enzyme from H. jecorina by Pail et 
al.
4
 was purified to homogeneity, whereas the others were characterized either as partially 
purified enzymes
3,5
 or as cell-free extracts.
6
  The Km value of N. crassa LAD was 16 mM f or L-
arabinitol, which when compared to LADs from H. jecorina and A. niger, is one of the lower 
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values reported of characterized LADs.  The values of 45 mM
5
 and 4.5 mM
4
 were reported for 
the same H. jecorina LAD, although the enzymes were purified from 
15
different heterologous 
hosts (S. cerevisiae and E. coli, respectively), with the former LAD being obtained by cleavage 
of a GST-fusion protein.  In addition, it is difficult to determine the effect of the larger Km,NAD+ of 
N. crassa LAD compared to other LADs, as no other characterizations reported both kcat and Km 
values for the cofactor.  With a specific activity of the purified N. crassa LAD equal to about 31 
U/mg, it is almost 20-fold greater than H. jecorina LAD purified from S. cerevisiae heterologous 
expression and orders of magnitude higher than other LADs except for A. niger LAD, which 
shows about three-fold greater specific activity than that of N. crassa LAD. However, it was also 
reported that the purified A. niger LAD was highly unstable, with rapidly diminishing activity at 
4 °C and complete loss of activity after freeze-thawing of the enzyme.
3
  In contrast, N. crassa 
LAD is quite stable and does not markedly lose activity when frozen repeatedly. 
There has been no in-depth study of the substrate binding residues for LAD, but the enzyme has 
been postulated to be a fungal orthologue of the eukaryotic D-SDHs
4
, which have been 
investigated more thoroughly.  Based on these reports, the active site substrate-binding residues 
are all strictly conserved in all LADs characterized to date (see Figure 2.6).  When comparing 
these residues in N. crassa LAD to SDHs, only F59 was not conserved, which instead was a 
tyrosine residue in all of the SDHs examined.  Mutational studies of this position were examined 
for F59A, F59S, and F59Y, to determine what effects this residue has on substrate specificity 
alteration, and are shown in Table 2.4.  Replacement of the native F59 residue with the 
homologous tyrosine found in SDH decreased the catalytic efficiency toward all active 
substrates.  The ability of LAD to bind each substrate markedly decreased as the size of the 
amino acid at position 59 was decreased.  Although these results suggest this residue is important 
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for binding and catalysis for the active substrates of the wild-type LAD, it did not confer the 
enzyme the ability to accept D-sorbitol as a substrate.  This confirms previously reported 
hypotheses that the amino acids flanking the active site cleft may be responsible for the activity 
and affinity patterns between LAD and SDH
4
.  The results were also recently confirmed in 
mutational analysis studies of A. niger LAD
15
.  An important finding of this study was the 
discovery of mutation F59Y, which abolished xylitol activity but did not eliminate L-arabinitol 
activity, although the kcat was lowered by ~33%.  It is possible this mutation could be necessary 
for the production of xylitol from L-arabinose from the combination of XR, LAD, and LXR, as 
LAD could continue to convert xylitol to D-xylulose.  However, as will be discussed in Chapter 
4, the low LAD activity with xylitol does not prevent xylitol from being detected from the three 
enzyme pathway. 
2.4. Conclusions and Future Work 
In conclusion, a gene from N. crassa encoding an LAD was cloned and purified in high yields.  
The enzyme is highly active and stable, acts on several five carbon sugar alcohol substrates, and 
operates over a wide pH range.  This enzyme should prove to be a useful starting point for the 
ultimate goal of the production of xylitol and ethanol from L-arabinose derived from renewable 
resources.  However, the newly characterized N. crassa LAD still has a strict preference for 
NAD
+
 over NADP
+
 as the native coenzyme.  In order to alleviate some of the cofactor 
regeneration issues that were mentioned in Chapter 1, engineering of the cofactor specificity of 
N. crassa LAD will need to be implemented to generate a successful strategy towards in vitro 
xylitol production and possibly in vivo ethanol fermentation.  The next chapter will focus on 
efforts to engineer the crucial cofactor-binding residues to introduce NADP
+
 activity into N. 
crassa LAD.  
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2.5. Materials and Methods 
2.5.1. Materials 
The Neurospora crassa genomic sequence and LAD protein sequences were accessed from the 
National Center for Biotechnology Information (NCBI, www.ncbi.nlm.nih.gov).  Neurospora 
crassa 10333 was obtained from the American Type Culture Collection (ATCC).  Escherichia 
coli BL21(DE3), GST-Bind resin, biotinylated thrombin, and streptavidin agarose were 
purchased from Novagen (Madison, WI).  E. coli WM1788 was kindly provided by Professor 
William Metcalf at the University of Illinois (Urbana, IL).  GST-fusion expression vector pGEX-
4T-3 was purchased from Amersham Biosciences.  SuperScript One-Step RT-PCR with 
Platinum

 Taq kit was obtained from Invitrogen (Carlsbad, CA).  Shrimp alkaline phosphatase, 
and PCR grade dNTPs were obtained from Roche Applied Sciences (Indianapolis, IN).  Phusion 
High-Fidelity DNA Polymerase and DNA-modifying enzymes DNase I, NdeI, SacI, and T4 
DNA ligase and their appropriate buffers were purchased from New England Biolabs (NEB) 
(Beverly, MA).  L-arabinitol, D-arabinitol, adonitol, xylitol, D-sorbitol, D-mannitol, ampicillin, 
kanamycin, isopropyl -D-thiogalactopyranoside (IPTG), NADH, NADP+, and NADPH were 
purchased from Sigma (St. Louis, MO).  NAD
+
 was a gift from Jülich Fine Chemicals (Jülich, 
Germany).  Other required salts and reagents were purchased from Fisher (Pittsburgh, PA) or 
Sigma-Aldrich.  The QIAprep spin plasmid mini-prep kit, QIAquick gel purification kit, RNeasy 
midiprep kit, and QIAquick PCR purification kit were purchased from Qiagen (Valencia, CA).  
Various oligonucleotide primers were obtained from Integrated DNA Technologies (Coralville, 
IA).  SDS-PAGE gel materials, electrophoresis equipment, protein size markers, size exclusion 
standards (catalog number 151-1901) and Bio-Sil SEC-250, 300 x7.8 mm column were 
purchased from Bio-Rad (Hercules, CA). 
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2.5.2. RT-PCR and Cloning (Notebook #1, p. 42; Notebook #2, p. 51) 
N. crassa 10333 was grown on rich potato media at 30 °C for 24 h and induced with 150 mM L-
arabinose for 2 hr.  Because the predicted gene contained one intron, reverse transcription PCR 
(RT-PCR) was utilized to isolate the processed gene.  Total ribonucleic acid (RNA) was purified 
from collected cells (RNeasy purification kit, Qiagen) and treated with DNase I to remove 
residual genomic DNA. RT-PCR was performed using SuperScript™ One-Step RT-PCR with 
Platinum
®
 Taq (Invitrogen) following the manufacturer‘s guidelines.  A control reaction 
consisted of the same protocol except for the SuperScript enzyme mix was heated to 95 ºC for 
ten minutes to thermally inactivate the reverse transcriptase enzyme and the reverse transcription 
thermocycler step was omitted.  The primers used for the RT-PCR were: forward 5′-GTA GCT 
ACG TCA GAA TTC CAT GGC TTC TAG CGC TTC C-3′ and reverse 5′-GCT GAT TCT 
GCG GCC GCT TAC TCC AGA CTC TGG ATC-3′.  The forward primer contained an EcoRI 
restriction site (shown in bold), while the reverse primer contained a NotI restriction site (shown 
in bold) and stop codon (italicized).  The resulting RT-PCR product was isolated by a QIAquick 
agarose gel purification kit and amplified by an additional 20 cycles of PCR. The product was 
digested with EcoRI and NotI restriction enzymes and purified again by agarose gel 
electrophoresis. It was then ligated into pGEX-4T-3 which had been previously prepared by 
EcoRI and NotI digestion, dephosphorylation by shrimp alkaline phosphatase, and gel 
purification. The ligation mixture was precipitated with n-butanol and resuspended in water.  The 
new construct was used to transform E. coli WM1788 by electroporation.  Positive clones were 
selected on Luria–Bertani (LB) solid media with ampicillin at 37 °C overnight. All colonies were 
then removed from the plates and grown to saturation in 5 mL liquid LB from which the 
plasmids were purified using a QIAprep spin plasmid miniprep kit, which were used to transform 
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E. coli BL21(DE3) by heat shock.  Positive clones were selected on LB solid media with 
ampicillin, picked individually, and assayed for LAD activity by the cell lysate assay described 
below.  Plasmids were sequenced using the BigDye
®
 Terminator sequencing method and an ABI 
PRISM 3700 sequencer (Applied Biosystems, Foster City, CA).  Sequencing results determined 
at the Biotechnology Center of the University of Illinois showed that the product had four silent 
mutations compared with the predicted sequence from the NCBI database. 
2.5.3. Lysate Assay 
E. coli BL21 (DE3) harboring the pGEX-4T-3-derived vector was grown to a maximum optical 
density at 600 nm (OD600) at 37 °C with shaking at 250 rpm. Fifty microliters was used to 
inoculate a new culture, which was grown at 37 °C with shaking at 250 rpm until an OD600 of 
~0.6 was reached.  The cultures were then induced with 0.3 mM IPTG and shaken at 250 rpm at 
25°C for 4 h.  One milliliter of cells was harvested by centrifugation and lysed by resuspension 
in 1 mL of 1 mg/mL lysozyme/50 mM Tris-HCl (pH 8.0). The cells were frozen at −80 °C and 
thawed at room temperature. The resulting lysate was vortexed thoroughly and centrifuged to 
remove cell debris.  Ten microliters of the lysate was used in a kinetic assay described below in 
the Enzyme Kinetics Section with 200 mM L-arabinitol and 2 mM NAD
+
 as the substrates in 50 
mM Tris (pH 8.0).  To determine soluble and insoluble expression, lysozyme was utilized as the 
lysis reagent for the induced and normalized cells following the manufacturer‘s 
recommendations, and samples were subsequently analyzed by SDS-PAGE.   
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2.5.4. GST-tag Removal (Notebook #2, p. 67) 
The N-terminal GST-tag was removed by incubation with biotinylated thrombin overnight at 4 
°C, incubation with streptavidin agarose for 30 min at 4 °C to remove thrombin, and passing 
mixture through GST-Bind resin to remove GST-tag, leaving five residues (GlySerProAsnSer) 
attached to the N terminus of the N. crassa LAD sequence.  To determine the effect of removal 
of the GST-tag, the purified LAD was incubated with and without thrombin at 4 °C overnight.  
Complete cleavage of the 25.7 kDa tag was verified by SDS-PAGE. The specific activities of the 
cleaved and noncleaved samples were compared.  It was determined that removal of the GST-tag 
enhanced activity by about 65%.  Because of this significant difference in activity, the cleaved 
enzyme was used in all subsequent assays. 
2.5.5. Enzyme Kinetics (Notebook #2, pp. 79-102) 
Initial rates were determined by measuring the initial rate of reaction as observed by the increase 
of absorbance at 340 nm using a Varian Cary 100 Bio UV-visible spectrophotometer (Varian, 
Palo Alto, CA) at 25 °C in 50 mM Tris-HCl (pH 8.0).  N. crassa LAD kinetic measurements 
with substrate L-arabinitol and cofactor NAD
+
 were taken in a five-by-five matrix format, with 
substrate and cofactor concentrations varied from below their Km to tenfold higher than their Km.  
The kinetic data were analyzed with a modified version of Cleland‘s program16.  Vmax and Km for 
both L-arabinitol and NAD
+
 were obtained by fitting the data to a sequential ordered mechanism 
with NAD
+
 binding first, based on the proposed mechanism for sorbitol dehydrogenase 
17
: 
v = VmaxAB/(KiaKB+KAB+KBA+AB)   (Eq. 1) 
39 
 
where v is the initial velocity, Vmax is the maximum velocity, KA and KB are the Michaelis-
Menten constants for NAD
+
 and L-arabinitol, respectively, A and B are the concentrations of 
NAD
+
 and L-arabinitol, respectively, and Kia is the dissociation constant for NAD
+
. 
N. crassa LAD kinetic measurements with alternate substrates were taken with varied 
concentrations of substrate sugar alcohol while keep NAD
+
 concentration saturating at 2 mM.  
The data were used to calculate the kinetic constants by fitting the Michaelis-Menten equation 
using Origin 5.0.  N. crassa LAD displayed typical Michaelis-Menten type kinetics with respect 
to all substrates tested except D-sorbitol.  The data represent averages of assays performed in 
duplicate or triplicate on two separate occasions. 
2.5.6. Thermal Dependence (Notebook #2, pp. 79-102) 
The optimal temperature of activity was determined by assaying N. crassa LAD activities at 
temperatures ranging from 12 to 65 °C in saturating substrate conditions.  Thermal inactivation 
of N. crassa LAD was studied by incubating at varied elevated temperatures in 50 mM Tris-HCl 
(pH 8.0), with samples removed at various times and assayed for activity in saturating substrate 
conditions.   
2.5.7. pH Rate Profile (Notebook #2, pp. 79-102) 
Activity was measured at pH values between 7.0 and 11.0 under saturating concentrations of 
NAD
+
 (2 mM) and L-arabinitol (200 mM) in a universal buffer (50 mM 
morpholineethanesulfonic acid (MES) / 50 mM Tris / 50 mM glycine).  Ionic strength of the 
universal buffer was taken into consideration according to previously established buffer 
compositions.
18
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2.5.8. Determination of Protein Mass and Quaternary Structure(Notebook #2, p. 202) 
The quaternary structure of native N. crassa LAD was determined using an Agilent 1100 series 
HPLC system with a Bio-Sil SEC-250 column (300 by 7.8 mm) and a mobile phase of 0.1 M 
Na2HPO4, 0.15 M NaCl, and 0.01 M NaN3, pH 6.8.  Monomerization was induced in the 
presence of 15% SDS and loaded onto the HPLC in similar fashion to the native enzyme to 
determine the N. crassa LAD monomer size. 
2.5.9. HPLC Analysis (Notebook #1, p. 186) 
The enzyme (1 g) was incubated in a mixture of buffer and 25 mM L-arabinitol with 1 mM 
NAD(P)
+
 at 37 C for 20 min.  The sample was eluted on a Zorbax 150 mm x 3.0 mm C-18 (3.5 
m) column with a UV detector (Agilent 1100 series).  The eluent consisted of two elements: 0.1 
M KH2PO4 containing 5 mM tetrabutylammonium hydrogen sulfate (pH 5.5) (buffer A) and 
100% methanol (buffer B).  The most suitable gradient was an initial isocratic step for 6 min at 
93% buffer A, a gradient for 5 min from 7 to 30% buffer B, and a final isocratic step for 5 min at 
30% buffer B. 
2.5.10. Homology Modeling 
Insight II was used to prepare the model (Insight II, version 2000; Accelrys Inc., San Diego, CA) 
and MOE (Chemical Computing Group Inc., Montreal, Canada) was used for optimization.  To 
verify the model, the overall fold was checked using Profiles3-D (Insight II), and the allowed 
states for and  angles and bond distances were checked using ProStat (Insight II), both with 
default settings.  The Profiles3-D (Insight II, default parameters) check resulted in a self-
compatibility score of 139.94, which compares well to the scores of 150.53 and 145.49 for the 
coordinates from 1PL8 and 1E3J, respectively.  The ProStat check of and  angles were 
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determined to be 81.2% within their core expected values, comparing well to the 83.3% and 
82.4% for the same analysis of PDB structures 1PL8 and 1E3J, respectively. 
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CHAPTER 3 – Engineering an NADP+-Dependent L-Arabinitol 4-
Dehydrogenase for Xylitol Production  
3.1.  Introduction 
The goal of my research project is to introduce the first three enzymes of L-arabinose metabolism 
into a model organism, Escherichia coli, and address the bottlenecks in the conversion of L-
arabinose and D-xylose to xylitol, with one of the main issues being the nicotinamide cofactor 
imbalance involved.  Xylose reductase (XR) and L-xylulose reductase (LXR) are preferably 
NADPH-dependent, whereas L-arabinitol 4-dehydrogenase (LAD) is NAD
+
-dependent.  This 
results in the formation of byproduct nicotinamide cofactors NADP
+
 and NADH, which must be 
regenerated by an organism‘s metabolism (Figure 3.1A).  In an attempt to reduce the burden 
placed on the cell to regenerate these accumulating cofactors, the use of an NADP
+
-dependent 
LAD would alleviate the imbalance partially (Figure 3.1B).  The resultant pathway would then 
require one equivalent of NADP
+
 to be regenerated, which has been shown to be possible in 
xylitol production from D-xylose alone in E. coli.
1,2
  However, there has been no report to date of 
a naturally occurring NADP
+
-dependent LAD.  It was then proposed to attempt to engineer the 
NAD
+
-dependent ncLAD (described in Chapter 2) into an NADP
+
-dependent ncLAD.  With the 
newly engineered enzyme, it was hypothesized that the partial alleviation of the cofactor 
imbalance could potentially lead to improved xylitol production from D-xylose and L-arabinose 
in a microbial host. 
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Figure 3.1.  Xylitol production scheme using D-xylose and/or L-arabinose as starting 
substrate.  (A) Wild-type pathway shows inherent difficulties associated with redox 
cofactor imbalance.  (B) Engineered pathway is designed with an NADP
+
-dependent 
LAD (in red) to regenerate NADPH and eliminate the need for NAD
+
 regeneration. 
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There exists a large body of literature describing the alteration of nicotinamide cofactor 
specificity
3-10
, including two review articles outlining the typical determinants and evolution of 
nicotinamide binding sites
11,12
.  Yet despite the prevalence of these attempts, altering cofactor 
specificity remains a challenge, as very few examples exist where catalytic efficiency for the 
initially disfavored cofactor has been improved such that it reaches the same level of efficiency 
as with the physiological cofactor.  Comparison of the strategies required to achieve efficient use 
of the non-physiological cofactor in these enzymes indicates that there is no clear formula for 
success, as mutations found in some enzymes do not necessarily translate to the same activity 
effect in another template enzyme.  As shown in Figure 3.2, NAD(H) and NADP(H) differ only 
in the phosphate group esterified at the 2‘-position of adenosine ribose, and therefore there are a 
limited number of amino acid residues interacting with this characteristic moiety that are suitable 
as the first candidates for protein engineering using site-directed mutagenesis.  The ability of 
polyol dehydrogenases to discriminate between NAD
+
 and NADP
+
 has been established to lie in 
the amino acid sequence of the -- motif of the coenzyme binding domain.  The primary 
determinant of NAD
+
 specificity is the presence of an aspartate residue, which forms double 
hydrogen bonds to both the 2‘- and 3‘-hydroxyl groups in the ribosyl moiety of NAD+ and 
induces negative electrostatic potential to the binding site. Commonly, this residue in NADP
+
-
dependent dehydrogenases is replaced by a smaller and uncharged residue such as Gly, Ala, and 
Ser, accompanied by the concurrent presence of an arginine residue that forms a positive binding 
pocket for the 2‘-phosphate group of NADP+.  Despite the prevalence of this information, the 
full reversal of coenzyme specificity, in terms of having a mutant enzyme catalytically efficient 
as the wild-type, has rarely been achieved. 
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Figure 3.2.  Structural comparison of nicotinamide cofactors.  NAD
+
 (top) and NADP
+
 
(bottom) are shown colored by atom.  Although these two cofactors tend to adapt slightly 
different bound conformations, the only structural difference is the 2‘-phosphate group 
found on the adenine ribose of NADP
+
. 
 
Sorbitol dehydrogenases (SDHs) are typically NAD
+
-dependent, but there is one reported case
13
 
from silverleaf whitefly Bemisia argentifolii that is the only known enzyme showing a strict 
preference to NADP
+
, and a crystal structure of the enzyme is available (Protein Data Bank 
[PDB] ID:1E3J)
14
.  Again, the homologous residues of the motif binding the signature phosphate 
moiety of NADP
+
 has the characteristics of a smaller residue (serine) and positively charged 
Nicotinamide end Adenine end 
NAD+ 
NADP+ 
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residue (arginine) in the cofactor binding pocket.  N. crassa LAD (ncLAD) shares homology 
with NADP
+
-dependent B. argentifolii SDH (43% identity, 61% positive), so it was expected 
that similar mutations would result in reversal of cofactor specificity. 
Xylitol dehydrogenases are also strongly NAD
+
-dependent as well, but there have been several 
reports of successful reversal of cofactor specificity towards NADP
+
.  Watanabe et al. described 
the engineering of NAD
+
-dependent XDH from yeast Pichia stipitis (psXDH), which resulted in 
completely reversing the coenzyme specificity to generate a novel NADP
+
-dependent XDH 
mutant by multiple site-directed mutagenesis
4
.  However, the mutations produced decreased 
thermostability compared with the wild-type enzyme, so the authors focused on a structural zinc 
atom that is not contained in native PsXDH.  Introduction of specific cysteine ligands into the 
enzyme gave an additional zinc-binding site and improved thermostability.  Furthermore, the 
catalytic efficiency of NADP
+
-dependent PsXDH was also improved by the introduction of an 
additional zinc atom.  Their best NADP
+
-dependent mutant XDH had three mutations 
(D207A/I208R/F209S) in the cofactor binding pocket near the phosphate moiety of NADP
+
, 
with three additional mutations (S96C/S99C/Y102C) used to introduce a second structural zinc 
later to stabilize their mutant enzyme.  The ncLAD enzyme already possesses the structural zinc 
motif and has been shown to contain two zinc ions per monomer (catalytic zinc and structural 
zinc), so it was promising that reversal of cofactor specificity in ncLAD could be attained 
without loss of stability. 
A double mutant (D38S/M39R) of the NAD
+
-dependent short-chain xylitol dehydrogenase from 
Gluconobacter oxydans (goXDH) was constructed that was able to use NADP
+
 exclusively.  In 
fact, the affinity for NADP
+
 was higher (Km = 206 M) than the wild-type enzyme for NAD
+
 
(Km = 348 M), with only a slight drop in kcat.   While the goXDH is a short-chain xylitol 
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dehydrogenase with a different fold and mechanism for catalysis than medium-chain sugar 
alcohol dehydrogenases (including ncLAD), the mutations conferring cofactor specificity are of 
the same type, with amino acids aspartate and methionine mutated to a smaller residue serine and 
positively-charged arginine, respectively. 
To the best of our knowledge, there has been no report of a naturally-occurring or engineered 
NADP
+
-dependent LAD enzyme in literature.  Therefore, initial attempts at reversing the 
cofactor specificity of N. crassa LAD were focused on determining the important residues 
involved in differentiating between NAD
+
 and NADP
+
 based on results from homologous 
enzymes sorbitol dehydrogenase (XDH) and xylitol dehydrogenase (SDH).  This work describes 
the successful engineering of a novel NADP
+
-dependent LAD enzyme using both rational design 
and directed evolution. 
3.2.  Results 
3.2.1.  Reversal of Cofactor Specificity of N. crassa LAD by Rational Design 
N. crassa LAD (ncLAD) shares homology with Pichia stipitis XDH (35% identity, 52% 
positive), and it was hypothesized that mutating the homologous residues to those that were 
reported to be important for cofactor specificity alteration from NAD
+
 to NADP
+
 would result in 
an efficient way to generate an NADP
+
-dependent ncLAD enzyme for later use in xylitol 
production or other value-added products from L-arabinose.  Therefore, a triple mutant ncLAD 
(D211A/I212R/D213S) was constructed and tested for cofactor activity.  However, there was no 
detectable activity with either NAD
+
 or NADP
+
 in the cell lysate activity assay, and later it was 
determined that the mutant was not found to be expressed in the soluble fraction following SDS-
PAGE analysis (data not shown).  A more systematic approach was deemed necessary to analyze 
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each residue in order to gain insight into which mutations would be important in reversing the 
cofactor specificity.  Single mutants of LAD were generated as described in the Materials and 
Methods section, and consisted of mutating D211 to smaller amino acid residues (Ala, Gly, Ser, 
Thr, or Val), I212 to a basic residue (Lys or Arg), and D213 to serine.  All of these were 
expressed in E. coli and SDS-PAGE analysis was performed to determine the solubility of these 
mutant LADs.  However, the solubility of these mutants was variable, with D211S, I212R, 
I212K and D213S being the most soluble, followed by D211A and D211G at about half of the 
wild-type enzyme level.  The solubilities of D211T and D211V were dramatically reduced 
compared to that of the wild type, although purification of these LADs from cell lysate did result 
in a small amount of recovered enzyme (~0.1-0.2 mg /g cells).  All mutant enzymes were 
purified to homogeneity and then analyzed by HPLC to determine the effects of the mutations, 
and three single mutants D211A, D211G, and D211S all showed improvements in NADP
+
 
activity. 
Based on the single mutant studies, engineering of ncLAD for reversal of cofactor specificity 
from NAD
+
 to NADP
+
 was continued, starting from the single mutants D211A, D211G, and 
D211S.  Position 212 in engineered NADP
+
-dependent xylitol dehydrogenase is an arginine 
residue, and has been shown to be arginine in both sorbitol dehydrogenase
14
, engineered 
phosphite dehydrogenase
9
, and engineered formate dehydrogenase
15
 to confer NADP
+
 
specificity/activity.  The double mutants ncLAD-AR, -GR, and -SR were created, expressed, and 
purified.  HPLC analysis showed further improved activity towards NADP
+
, with the largest 
gains in activity being with ncLAD-AR and ncLAD-SR. 
The last rational design attempt at incorporating homologous residues from other NADP
+
-
dependent enzymes was D213S.  Introduction of this mutation in the background of ncLAD-AR 
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was attempted to begin with, which resulted in an enzyme that was not expressed in the soluble 
fraction, so the mutation was placed into the remaining two double mutants, ncLAD-SR and 
ncLAD-GR, and also resulted in significantly decreased expression.  Although no increased 
activity was found, the decrease in activity suggested this position was important for binding 
NADP
+
.   
Saturation mutagenesis libraries at residue D213X on both the ncLAD-AR and ncLAD-SR 
templates were created and screened for activity as detailed in the Materials and Methods 
Section.  Positive mutants with >25% activity than the parent from the ncLAD-SR screen were 
found, with none from the ncLAD-AR parent library, and were selected and verified by tube 
assay to have improved activity.  All clones verified were sequenced and found to have an 
asparagine residue in position 213.  This triple mutant was named ncLAD-SRN.  As shown in 
Table 3.1, ncLAD-SRN displayed almost 1.4-fold higher kcat than parent ncLAD-SR, but 
suffered a 3-fold loss in affinity as the Km,NADP rose from 0.48 mM for ncLAD-SR to 1.45 mM 
for ncLAD-SRN.  The overall catalytic efficiency decreased 2-fold.  Unfortunately, the ncLAD-
SRN mutant was also significantly less stable than the ncLAD-SR parent, with high amount of 
precipitated enzyme occurring during the buffer exchange and concentration steps of the 
purification protocol (Materials and Methods Section).  This could explain why the measured 
catalytic efficiency of ncLAD-SRN was lower than ncLAD-SR, because the screen should have 
resulted in improvement of this property.  Despite having generated a successful LAD mutant 
(ncLAD-SR) with specificity now towards NADP
+
 and minimal activity towards NAD
+
, the low 
affinity for NADP
+
 was still of major concern.  The intracellular concentrations of NADP
+
 in E. 
coli range from 0.1 mM – 0.4 mM16-18, based on converting reported values with estimated 
intracellular E. coli cell volumes
19,20
.  It would be desired to have a mutant LAD with Km values 
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at or below these levels for optimal performance.  Saturation mutagenesis libraries of residues 
surrounding the rational design targets (210X, 214X, 215X) were also generated and screened, 
without any positive hits found.  Therefore attention was shifted to attempt directed evolution on 
ncLAD-SR template. 
3.2.2.  Screening Procedure Validation and EP-PCR Results 
Before attempting to screen a mutant library, particularly a larger-size library generated from 
error-prone PCR (EP-PCR), it is particularly important to verify the reproducibility of the 
screening procedure
21,22
.  Variability inherent in every screen arises from various factors such as 
varying cell growth rates, expression of enzyme from multiple-copy vectors, cell lysis efficiency, 
pipetting errors, etc.  These variations must be minimized in order to eliminate false positives 
and simplify data interpretation. 
The production of NAD(P)H at 340 nm is commonly used to measure the activity of 
dehydrogenases.  Therefore, a 96-well plate screening assay was developed for high-throughput 
analysis of a library of error-prone PCR mutants of ncLAD-SR.  E. coli BL21(DE3) cells 
harboring plasmid pET-28a ncLAD-SR were used to inoculate 96-well plates and following 
growth, induction, and lysing steps, the reproducibility of NADP
+
 activity measurement was 
tested by calculating the coefficient of variance (CV).
21
  The assay was confirmed to be 
sufficient with a coefficient of variance (CV) of approximately 15%. 
After the screening procedure was validated, the optimization of the diversity of the error-prone 
library was addressed.  The diversity of a mutant library is dependent on the level of 
mutagenesis, which can be modified by varying the concentration of Mn
2+
 in the PCR reaction
21
.  
Three different libraries of ncLAD-SR, created using 0.10, 0.15, and 0.20 mM Mn
2+
 were tested 
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with the validated screening procedure.  Based on these results, an optimal concentration of 0.15 
mM Mn
2+
 resulted in 40-50% of the clones being inactive, which correlates to approximately 1-2 
amino acid substitutions per gene.  ncLAD has 364 amino acids, so a library of this size can have 
7,280 single amino acid substitutions.  However, due to codon degeneracy and that in most cases 
only a single nucleotide within a single codon is altered, only about 6 amino acids can be 
accessed by EP-PCR.  This results in a library of about 2,200 potentially different clones.  A 
library size of 3-5 times this size must be screened in order to have a 95% confidence level of 
screening all possible variants, which can easily be screen with the 96-well plate assay.  
Therefore, after screening a little more than 6,000 clones, a final mutant LAD, ncLAD-3x, was 
discovered and characterized. 
3.2.3.  Kinetic Data of the Engineered ncLAD Mutants 
The kinetic parameters of the parent wild-type and engineered mutant ncLAD enzymes towards 
substrates NAD
+
, NADP
+
, and L-arabinitol are listed in Table 3.1.  The best first round rational 
design generated mutant, D211S, showed a dramatic decrease in activity towards NAD
+
, with 
minimal yet detectable activity increase towards NADP
+
.  The best second round rational design 
mutant, D211S/I212R, displayed a significant reversal in cofactor specificity, although still had 
~5-fold lower kcat/Km than the wild-type had with NAD
+
.  With rational design targets exhausted, 
a round of EP-PCR and screening via 96-well plate format resulted in the discovery of ncLAD-
3x, which contained a third mutation S348T.  In addition, activity with NAD
+
 was also kept low, 
only slightly above background activity. This result was promising, as the goal of the 
engineering effort was to not only improve activity towards NADP
+
, but to also minimize 
activity with NAD
+
, such that the cofactor imbalance in the wild-type xylitol pathway could be 
handled by inclusion of a suitable co-substrate to regenerate the excess NADP
+
.  However, as 
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shown in Table 3.2, an unfortunate artifact of the screening procedure was the subsequent loss of 
affinity for substrate L-arabinitol of the mutant ncLAD-3x (Km,L-arabinitol of ~290 mM) compared 
to the wild-type (Km,L-arabinitol of ~12 mM).  As a result, the catalytic efficiency is also 
substantially reduced from 64 mM
-1
min
-1
 for the wild-type to 4 mM
-1
min
-1
 ncLAD-3x. This loss 
of affinity and catalytic efficiency came about despite keeping the L-arabinitol concentration of 
the screening assay at 20 mM, which was near the wild-type Km,L-arabinitol value.  Intermediate 
mutants ncLAD-S and ncLAD-SR could not be saturated for sufficient kinetic parameter 
analysis. 
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Table 3.1.  Kinetic parameters of ncLAD mutants for nicotinamide cofactors. 
 NAD
+
 NADP
+
 
Enzyme kcat Km kcat/Km kcat Km kcat/Km 
 min
-1
 mM mM
-1
min
-1
 min
-1
 mM mM
-1
min
-1
 
ncLAD-wt 650   
± 25  
0.14    
± 0.03 
4740           -
a
 >8 <30 
ncLAD-S 515   
± 21 
2.9        
± 0.3 
175             -
a
 >5 <40 
ncLAD-SR 191    
± 17 
3.6       
± 0.7 
53                494          
± 26 
0.48     
± 0.08 
1030               
ncLAD-
SRN 
-
a
 >5 <100 714           
± 8 
1.45       
± 0.05 
496                 
ncLAD-3x -
a
 >5 <100 1210         
± 44 
0.55      
± 0.09 
2190 
a
Not determined, saturation of cofactor not reached 
All assays run at 25 C, 50 mM Tris-HCl pH 8.0 
All enzymes were purified and characterized with N-His6Tag 
 
Table 3.2.  Kinetic parameters of ncLAD mutants for substrate L-arabinitol. 
Enzyme kcat Km kcat/Km 
 min
-1
 mM mM
-1
min
-1
 
ncLAD-wt 736 ± 110 11.6 ± 0.9 64 
ncLAD-S -
a
   > 1000  -
a
 
ncLAD-SR -
a
  > 500 -
a
 
ncLAD-3x 1190 ± 390 292 ± 110 4  
a
Not determined, saturation of cofactor not reached 
All assays run at 25 C, 50 mM Tris-HCl pH 8.0 
All enzymes were purified and characterized with N-His6Tag 
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3.3.  Discussion 
3.3.1.  Protein Engineering Strategy 
Initial attempts to alter the cofactor specificity of N. crassa LAD were conducted in similar 
fashion to the successful cofactor reversal of xylitol dehydrogenase
4
.  However, when 
introducing similar mutations and generating a triple mutant (D211A/I212R/D213S), a cell lysate 
assay resulted in no significant activity increase from the background in converting NADP
+
.  
One possible reason behind this result was that the mutations introduced were not suitable for 
cofactor specificity change in the context of N. crassa LAD.  Another possibility was that the 
cell lysate assay was not sensitive enough to detect the subtle increase in activity that could result 
from mutagenesis, as the wild type enzyme did not show any detectable cell lysate activity on its 
own towards NADP
+
.  SDS-PAGE analysis also showed that the triple mutant was not expressed 
in the soluble fraction (data not shown), which could have also been a reason for no increased 
activity being detected.  A more systematic approach was then taken (Figure 3.3) to engineer an 
NADP
+
-dependent LAD enzyme. 
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Figure 3.3.  Lineage and protein level mutations of the engineered LAD variants.  Mutant 
enzymes outlined were purified and kinetics characterized in Table 3.1.  
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Another attempt was to develop a screening method to determine beneficial mutations 
incorporated by site-directed saturation mutagenesis of the proposed important residues that 
conferred cofactor specificity.  However, the lack of sensitivity in the high-throughput 96-well 
plate assay resulted in no positive mutants being identified with increased affinity for NADP
+
.  A 
third attempt at improving NADP
+
 affinity was based on HPLC analysis in which the generation 
of NADPH could be detected with much higher sensitivity when compared to the 96-well plate 
or test tube based activity assays.  As mentioned in Chapter 2, HPLC analysis was able to show 
that the wild type N. crassa LAD did indeed possess activity with NADP
+
, although with an 
exceedingly low kcat/Km value of ~6.5 x 10
-7
 M-1 min-1.  Single mutants of LAD were generated 
as described in the Materials and Methods section, and consisted of mutating D211 to smaller 
amino acid residues (Ala, Gly, Ser, Thr, or Val), I212 to a basic residue (Lys or Arg), and D213 
to serine.  The best mutants (D211A, D211G, and D211S) were then subjected to site-directed 
mutagenesis for introduction of arginine at position 212, with improvements found in ncLAD-
AR and ncLAD-SR.  Targeting position 213 with replacement with serine did not improve 
activity and resulted in insoluble protein.  However, the double mutants provided a reproducible 
positive control in a 96-well plate formatted screening procedure, and saturation mutagenesis at 
position 213 was performed.  The best mutant found had a D213N mutation, but this enzyme was 
found to be less stable than previous rounds, with noticeable amounts of white precipitate 
forming during purification and concentration, leading to kinetic parameter analysis that did not 
match the screening results.  Therefore, the best double mutant, ncLAD-SR, was used in an 
error-prone PCR library screen in an attempt to enhance NADP
+
-activity and improve solubility 
and stability.  The final mutant, ncLAD-3x, contained the two rational design mutations 
(D211A/I212R) and a third mutation S348T.  It should be noted that a second round of EP-PCR 
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was attempted with ncLAD-3x as the parent, but no improvement in NADP
+
-dependent activity 
was able to be found. 
3.3.2.  Properties of the ncLAD-3x Mutant 
This work resulted in the engineering of an NADP
+
-dependent LAD, ncLAD-3x.  From the 
cofactor kinetics, the kcat value of 1210 min
-1
 was close to 2-fold higher than the wild type value 
of 650 min
-1
.  And while the Km,NADP+ value of 0.55 mM was slightly higher than the template 
ncLAD-SR Km,NADP+ value of  0.48 mM, the catalytic efficiency for NADP
+
 experienced an 
almost 2-fold increase from 1030 to 2190 mM
-1
 min
-1
. The decrease in affinity for substrate L-
arabinitol, going from Km,arabinitol of 20 mM for the wild-type to Km,arabinitol of 200 mM for 
ncLAD-3x, was an unfortunate artifact of the screen.  Although the concentration of L-arabinitol 
was kept at a low level (25 mM) in the screening procedure, the improvement in the NADP
+
-
activity apparently masked this effect. 
3.3.3.  Structural Analysis of the Mutations 
There is currently not a crystal structure of L-arabinitol 4-dehydrogenase available from any 
source organism.  Therefore, a homology model of wild-type ncLAD was built using Insight II 
software (Accelrys, San Diego, CA) during the engineering efforts.  The NAD
+
-dependent 
human sorbitol dehydrogenase (SDH, PDB ID:1PL8
23
) and NADP
+
-dependent SDH from 
silverleaf whitefly, Bemisia argentifolii (PDB ID:1E3J
14
) were used as templates, sharing 44% 
and 43% homology with ncLAD, respectively.  The resulting model was docked with NAD
+
 and 
the catalytic zinc ion and subjected to energy minimization by using the Molecular Operating 
Environment (MOE, Chemical Computing Group, Montreal, Canada) program.  Based on this 
structural model, the molecular basis for reversal of cofactor specificity was further probed. 
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Figure 3.4.  Homology model illustration of cofactor binding interactions of ncLAD-wt.  
Only the adenine portion of NAD(P) is shown for clarity.  A) LAD bound with NAD
+
 in 
the active site, showing favorable interaction through hydrogen bonding between D211 
and the 2‘-hydroxyl of the adenine ribose.  B)  With NADP+ bound, however, D211 and 
the adenine ribose 2‘-phosphate of NADP+ are electrostatically repulsed, resulting in poor 
binding and significantly reduced activity due to the strong steric hindrance. 
 
Firstly, the docked NAD
+
 cofactor in the wild-type molecule was changed to NADP
+
 using the 
builder tool in MOE and then subjected to energy minimization.  When the phosphate moiety of 
NADP
+
 is present in the wild-type model, there are both unfavorable electrostatic repulsions and 
steric interactions that prevent proper binding of the NADP
+
 cofactor (Figure 3.4).  As in most 
dehydrogenase domains that bind NAD
+
, the space that would be taken up by the extra 
phosphate of NADP
+
 is occupied by the conserved hydrogen bond between the aspartate in the 
binding site (D211 in N. crassa LAD) and the adenosine ribose of the NAD
+
 
24
. 
During the course of the engineering efforts, the crystal structure of ncLAD-wt was obtained in 
collaboration with Brian Bae in Dr. Satish Nair's group (manuscript in preparation).  Figure 3.5A 
shows the comparison of the monomeric structure of ncLAD in the homology model versus the 
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crystal structure.  The catalytic domain (left-hand side of the figure) shows slightly more 
deviation, particularly among the loop structures, between the model and the crystal structure 
than with the cofactor binding domain (right hand side of the figure).  This is to be expected as 
the template structures used for the modeling were either with NAD
+
 bound (1PL8) or with no 
cofactor ligand bound (1E3J), and the enzyme is known to have a hinge region between the two 
domains that closes when ligand is bound.  However, as shown in Figure 3.5B, the residues in 
the cofactor binding site as well as the docked NAD
+
 ligand in the homology model were very 
closely arranged as in the crystal structure, with only a slight turn in the I212 residue being the 
most noticable difference.  Regardless, the model was deemed suitable enough for the earlier 
cofactor binding analysis, but the S348 residue was pointed in the opposite direction entirely, so 
the crystal structure was used to analyze the mutations found in ncLAD-3x.  
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Figure 3.5.  (A) Comparison of the monomeric ncLAD subunit in the homology model (shown in 
red) and the crystal structure (shown in blue).  The structural zinc ion is only shown for the 
crystal structure as this was not docked into the homology due to the engineering efforts focusing 
on the cofactor binding site.  (B) Cofactor binding domain of homology model (shown as lines) 
and the crystal structure (shown as sticks). 
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The three mutations in ncLAD-3x were introduced into the crystal structure using MOE and 
energy minimized, and the engineered cofactor binding site is shown in Figure 3.6.  The D211A 
substitution served to open up the cofactor binding pocket for the phosphate moiety to enter, as 
well as remove the negatively charged electrostatic repulsion of aspartate with phosphate.  The 
second rational design target residue, I212R, introduced a positively charged residue to balance 
the negative charge of the phosphate moiety of NADP
+
.  The final mutation found from directed 
evolution screening, S348T, is located between two alpha helices approximately 6.9 angstroms 
from the phosphate moiety of the docked NADP
+
 molecule, and does not appear to form any 
direct contact with the cofactor.  The side chain atoms are actually positioned away from the 
phosphate moiety.  However, it is possible this mutation alters the positioning of surrounding 
helix structures to enable more space for the extra phosphate moiety to position itself in the 
cofactor binding pocket, along with making the pocket too large for the wild-type‘s preferential 
cofactor, NAD
+
, to be held securely.  It should be noted that the improvement of ncLAD-3x over 
the double mutant was mostly attributed to an increase in kcat.  The mutation S348T also is 
located on the opposite end of the alpha helix in close proximity to the catalytic zinc.  Therefore, 
it is entirely possible that the S348T mutation served to alter the secondary structure of the 
enzyme such that the catalytic site was modified to improve the turnover number and/or reduce 
the affinity for substrate L-arabinitol.  Saturation mutagenesis and subsequent screening of the 
library did not result in finding a mutant with improved NADP
+
 activity, so no efforts were made 
to generate and characterize other mutants at this site to determine the true nature of the 
mutation‘s effect. 
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Figure 3.6.  Illustration of cofactor binding interactions of ncLAD-3x with NADP
+
, based off of 
the ncLAD-wt crystal structure. 
 
3.4.  Conclusions 
The cofactor specificity of L-arabinitol 4-dehydrogenase from Neurospora crassa was 
successfully reversed from NAD
+
 to NADP
+
 preference.  Two mutations, D211S and I212R, are 
similar to those found in other NADP
+
-dependent dehydrogenase enzymes, and a third mutation, 
S348T, is the first of its position to be described to influence LAD activity.  Modeling the third 
mutation showed the difficulty in choosing this position to mutate rationally, showing that 
directed evolution can aid in cases where rational design targets have been exhausted.  The 
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combined rational design and directed evolution approaches resulted in the isolation of ncLAD-
3x with 2-fold improvement in kcat, and a catalytic efficiency with NADP
+
 close to the wild-type 
with NAD
+
.  With a novel NADP
+
-dependent LAD developed, attention can be shifted towards 
designing and implementing an engineered fungal pathway for production of xylitol from 
hemicellulosic sugars, which will be addressed in Chapter 4. 
3.5.  Materials and Methods 
3.5.1.  Materials 
Escherichia coli BL21 (DE3) and pET-28a were purchased from Novagen (Madison, WI).  
Ampicillin, kanamycin, isopropyl--D-thiogalactopyranoside (IPTG), NAD, NADP, NADH, and 
NADPH were obtained from Sigma-Aldrich (St. Louis, MO).  Other salts and reagents were 
purchased from either Fisher (Pittsburg, PA) or Sigma-Aldrich.  Co
2+
 Talon immobilized metal 
affinity resin was purchased from Clontech BD biosciences (San Jose, CA).  Amicon® Ultra-15 
filter devices were purchased from Millipore.  Restriction enzymes and T4 DNA ligase were 
purchased from New England Biolabs (Beverly, MA).  Kits for plasmid purification, gel and 
column purification of DNA fragments were obtained from Qiagen (Valencia, CA).  DNA 
oligonucleotide primers were obtained from Integrated DNA Technologies (Coralville, IA). 
3.5.2.  Site-Directed and Saturation Mutagenesis 
A megaprimer PCR method for site-directed mutagenesis
25
 was utilized to introduce site-specific 
mutations using purified plasmid pET-28a ncLAD-wt as the template.  Two oligonucleotide 
primers flanking the LAD gene were used in combination with the mutagenic primers listed in 
Table 3.3.  For the construction of each mutant, the first step was the creation of the megaprimer 
piece, using the forward mutagenic primer and reverse flanking primer.  After PCR purification, 
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a second PCR reaction was run, this time with the forward flanking primer and the megaprimer 
piece from the previous reaction utilized as primers for amplification.  The correctly sized gene 
products (~1.1 kb) were purified from the agarose gel after DNA electrophoresis and another 
round of amplification was run with the flanking primers to increase product yield when 
necessary.  Products of the correct size were isolated by gel electrophoresis, digested with NdeI 
and SacI, and ligated into the NdeI-SacI digested, dephosphorylated pET-28a(+) vector as N-
terminal His6-Tag fusions.  Chemically competent E. coli BL21(DE3) were then transformed 
with the ligation mixtures by heat shock treatment and grown on agar plates containing 50 
g/mL kanamycin.  Several colonies were picked and clones were first analyzed by colony PCR 
to ensure the gene insert was incorporated into the pET-28a vector.  Cultures of the clones with 
correct sized inserts were grown again and the subsequently isolated plasmids were sequenced in 
both directions at the Biotechnology Center of the University of Illinois using the Big Dye
TM
 
Terminator sequencing method and an ABI PRISM
®
 3700 sequencer (Applied Biosystems, 
Foster City, CA).  Sequencing of the mutant genes was conducted to confirm correct mutations 
were introduced and to eliminate the chance of PCR-introduced random mutations being 
incorporated into the final DNA construct.  Colonies with plasmids containing the correct mutant 
genes were used for protein expression and purification. 
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Table 3.3.  Primers sequences used in site-directed mutagenesis and saturation mutagenesis of ncLAD.  
Restriction sites are shown in bold.  Codons underlined encode the mutations incorporated. 
Primer Name DNA Sequence (5‘→3‘) 
Fwd ncLAD NdeI 5‘-GTA GCT ACG TCA CAT ATG GCT TCT AGC GCT TCC AAG-3‘ 
Fwd ncLAD D211A 5‘-CTT GTC ATT ACC GCC ATT GAC GAA GGC CGC TTG-3‘ 
Fwd ncLAD D211G 5‘-CTT GTC ATT ACC GGN ATT GAC GAA GGC CGC TTG-3‘ 
Fwd ncLAD D211S 5‘-CTT GTC ATT ACC TCN ATT GAC GAA GGC CGC TTG-3‘ 
Fwd ncLAD D211T 5‘-CTT GTC ATT ACC ACN ATT GAC GAA GGC CGC TTG-3‘ 
Fwd ncLAD D211V 5‘-CTT GTC ATT ACC GTN ATT GAC GAA GGC CGC TTG-3‘ 
Fwd ncLAD I212R 5‘-CTT GTC ATT ACC GAC CGT GAC GAA GGC CGC TTG-3‘ 
Fwd ncLAD D213S 5‘-CTT GTC ATT ACC GAC ATT TCC GAA GGC CGC TTG-3‘ 
Fwd ncLAD D211A/I212R 5‘-CTT GTC ATT ACC GCC CGT GAC GAA GGC CGC TTG-3‘ 
Fwd ncLAD D211G/I212R 5‘-CTT GTC ATT ACC GGN CGT GAC GAA GGC CGC TTG-3‘ 
Fwd ncLAD D211S/I212R 5‘-CTT GTC ATT ACC TCN CGT GAC GAA GGC CGC TTG-3‘ 
Fwd ncLAD D211A/I212R/D213S 5‘-CTT GTC ATT ACC GCC CGT TCN GAA GGC CGC TTG-3‘ 
Fwd ncLAD D211G/I212R/D213S 5‘-CTT GTC ATT ACC GGN CGT TCN GAA GGC CGC TTG-3‘ 
Fwd ncLAD D211S/I212R/D213S 5‘-CTT GTC ATT ACC TCN CGT TCN GAA GGC CGC TTG-3‘ 
Fwd ncLAD D211S/I212R/D213X 5‘-CTT GTC ATT ACC TCN CGT NNS GAA GGC CGC TTG-3‘ 
Rev ncLAD SacI 5‘-AGC TGA TAG CGA GCT CTT ACT CCA GAC TCT GGA TC-3‘ 
 
3.5.3.  Error-Prone PCR Mutagenesis and Library Creation (Notebook #3, p. 130) 
Random mutagenesis was carried out using error-prone PCR
26
.  The following stock solutions 
were prepared for the PCR protocol.  A stock solution of 10X Mutagenic Buffer was prepared 
containing 70 mM MgCl2, 500 mM KCl, 100 mM Tris-HCl (pH 8.3 @ 25 °C), and 0.1% 
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(wt/vol) gelatin.  A stock solution of 5 mM MnCl2 was prepared by dilution of a stock of 250 
mM MnCl2.  For a mutagenesis rate of ~1-2 amino acid substitutions per gene product, it was 
established by an initial experiment with varied MnCl2 concentrations and subsequent 
sequencing of a number of the resultant clones that a final concentration of 0.15 mM MnCl2 was 
to be included in the PCR mixture.  A 10X stock solution of unbalanced dNTPs was prepared 
containing 2 mM dATP, 2 mM dGTP, 10 mM dCTP, and 10 mM dTTP. 
In a 0.6 mL thin-wall PCR tube, 10 L of 10X Mutagenic Buffer, 3 L of 5 mM MnCl2, 50 ng 
parent template plasmid DNA, 50 pmole of T7-fwd primer (5‘-
TAATACGACTCACTATAGGG-3‘), 50 pmole of T7-rev primer (5‘-
GCTAGTTATTGCTCAGCGG-3‘), 10 L of 10X unbalanced dNTPs, and an amount of water 
to bring the mixture volume to 99 L.  1 L of Taq DNA Polymerase (5 U/mL, Roche Applied 
Science, Indianapolis, IN) was added and mixtures were gently mixed by pipetting.  The error-
prone PCR reaction was carried out in an MJ Research PTC-200 thermal cycler (Watertown, 
MA) with the following program: 
Step 1 = 94 °C for 4:00 
 Step 2 = 94 °C for 0:45 
 Step 3 = 55 °C for 0:45 
 Step 4 = 72 °C for 1:45 
 Step 5 = Goto 2, 18 times 
 Step 6 = 72 °C for 5:00 
 Step 7 = 4 °C for ever 
 Step 8 = End 
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PCR products were run on a 1% Tris Acetate EDTA gel and purified by using a QiaQuick® Gel 
Extraction Kit (Qiagen, Valencia, CA).  PCR products were then digested with NcoI and SacI 
and ligated into pET-28a vector digested with the same two restriction enzymes.  Digested pET-
28a was also dephosphorylated with alkaline phosphatase (New England Biolabs, Ipswich, MI) 
prior to ligation to lower background of subsequent transformation.  Ligation reactions of 10 L 
final volume contained 100 ng vector, 60 ng insert (3:1 insert to vector molar ratio), 1X T4 DNA 
Ligase Buffer, and 0.5 U T4 DNA Ligase, and were incubated at either room temperature for 1 h 
or overnight at 16 °C.  The ligated library was transformed into freshly prepared 
electrocompetent E. coli BL21(DE3) cells, which were then plated onto Luria-Bertani (LB) agar 
plates containing 50 g/mL kanamycin.  Viable colonies each contained one mutant gene, and 
were used to inoculate media-containing 96-well plates for activity screening, as described below 
in Section 3.5.4. 
3.5.4.  Activity Assay Screening Procedure (Notebook #3, p. 136) 
To identify LAD mutants that showed improved NADP
+
 activity while keeping NAD
+
 activity 
limited, a 96-well plate based screening procedure was developed.  Library colonies were 
selected with sterile toothpicks and placed into single wells to inoculate 96-well plates 
containing 100 L LB media supplemented with 50 g/mL kanamycin.  The plates were secured 
in place by placement in plastic pipette tip boxes and incubated at 37 °C for five hours with 
shaking (250 rpm).  The cell cultures were then induced with IPTG (final concentration of 0.3 
mM IPTG) followed by incubation at 30 °C for 12-16 hours overnight.  Plates were wrapped 
with wetted towels to prevent too much evaporation from occurring to the outside wells of the 
96-well plates.  After protein expression, the plates were centrifuged at 4,000 rpm for 15 minutes 
and the media was decanted.  Cell pellets were lysed by resuspension in 100 uL lysis buffer 
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consisting of 100 mM phosphate buffer (pH 7.0) with 1 mg/mL lysozyme.  Adhesive labels were 
placed on the 96-well plates and vortexed until cell pellets were uniformly resuspended, and then 
followed by a freeze-thawing step.  96-well plates containing cell lysates were then centrifuged 
at 4,000 rpm at 4 °C for 15 minutes, and 20 mL of cell lysates was transferred to a fresh 96-well 
plate.  Addition of 100 L of activity assay mix comprised of 100 mM KH2PO4 buffer (pH 7.0), 
25 mM L-arabinitol, and 0.125 mM NADP
+
 was immediately followed by monitoring the change 
in absorbance at 340 nm for 5 minutes in a SpectraMax 340PC microplate reader (Molecular 
Devices, Sunnyvale, CA) to determine the initial activities of each library mutant.  Mutants with 
increased activity towards NADP
+
 were found by comparison to the parent enzyme, which was 
inoculated in triplet for each 96-well plate screened.  One well was also reserved for the wild-
type enzyme to serve as a negative control for the assay.  Positive mutants with the improved 
activity towards NADP
+
 were verified by scale up of the 96-well screening procedure to a 14 mL 
tube assay variation. 
3.5.5.  DNA Sequencing and Analysis 
Plasmid DNA from E. coli BL21(DE3) was isolated using QIAprep® spin Miniprep kit (Qiagen, 
Valencia, CA).  Sequencing reactions contained 50 ng of template plasmid DNA, 10 pmole of 
primer, 1X BigDye sequencing buffer, and the BigDye reagent (Applied Biosystems, Foster 
City, CA).  Reactions were carried out in an MJ Research PTC-200 thermal cycler (Watertown, 
MA).  Samples were submitted to the Biotechnology Center at the University of Illinois for 
sequencing on an ABI PRISM® 3700 sequencer (Applied Biosystems, Foster City, CA).  The 
sequencing reaction program was as follows: 
 Step 1 = 96 °C for 2:00 
 Step 2 = 96 °C for 0:20 
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 Step 3 = 50 °C for 0:10 
 Step 4 = 60 °C for 3:50 
 Step 5 = Goto 2, 30 times 
 Step 6 = 4 °C for ever 
 Step 7 = End 
3.5.6.  LAD Over-Expression and Purification (Notebook #4, p. 230-231) 
Protein purification of wild-type or mutant LAD enzymes was carried out in a protocol described 
elsewhere with some modifications.
27
  E. coli BL21(DE3) pET-28a ncLAD cells were grown in 
2 L baffled flasks containing 600 mL Luria-Bertani (LB) medium supplemented with kanamycin 
(50 g/mL).  Cells were grown at 37 °C to OD600 ~0.6 and then induced with IPTG to a final 
concentration of 0.3 mM.  The culture was incubated at 30 °C for an additional 6 hours, after 
which the cells were harvested by centrifugation (15 min at 10,000 rpm) and resuspended in 20 
mL Buffer A, composed of 20 mM Tris-HCl (pH 7.2 at 4 C), 15% glycerol, and 0.5 M NaCl.  
Lysozyme (1 mg/mL) was added to the resuspended cells and the sample was incubated at room 
temperature for 15 minutes and then freeze-thawed.  The cells were further lysed by French 
press, cell debris was removed by centrifugation at 13,000 rpm for 15 minutes (twice), and cell 
lysate was filtered with 0.45 m syringe filters prior to affinity column loading.  The N-His6-
tagged enzymes were purified using immobilized metal affinity chromatography (IMAC).  
TALON
TM
 Superflow Co
2+
 resin (Clontech, Mountain View, CA) was charged and equilibrated 
with buffer A according to manufacturer‘s instructions.  The clarified supernatant was loaded 
onto the resin and washed with Buffer A.  Non-specifically binding proteins were removed by 
washing the column with Buffer A with 10 mM imidazole (Buffer B).  His6-tagged proteins were 
eluted from the column with Buffer A with 250 mM imidazole (elution buffer).  Proteins were 
concentrated using a Millipore Amicon Ultra-15 centrifugal filter device (MWCO = 10 kDa) at 
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4,000 rpm at 4 °C, washed three times with 50 mM 4-(2-Hydroxyethyl)piperazine-1-
ethanesulfonic acid (HEPES) buffer (pH 7.2) containing 15% glycerol, and concentrated.  
Concentrated proteins were stored at -80 °C.  Protein concentration was determined using Bio-
Rad Protein Assay with BSA as standard. 
3.5.7.  HPLC Analysis of Products 
The mutant enzyme (10 g) was incubated in a mixture of buffer and 250 mM L-arabinitol with 
2.5 mM NAD(P)
+
 at 37 C for 30 min.  The sample was eluted on a Zorbax 150 mm x 3.0 mm 
C-18 (3.5 m) column with a UV detector (Agilent 1100 series).  The eluent consisted of two 
elements:  0.1 M KH2PO4 containing 5 mM tetrabutylammonium hydrogen sulfate (pH 5.5) 
(buffer A) and 100% methanol (buffer B).  The most suitable gradient was an initial isocratic 
step for 6 min at 93% buffer A, a gradient for 5 min from 7 to 30% buffer B, and a final isocratic 
step for 5 min at 30% buffer B. 
3.5.8 Enzyme Kinetics (Notebook #4, p.232) 
The kinetic rate constants for the purified N-His6tagged wild-type and mutant LAD enzymes 
were determined as described elsewhere
28
.  Briefly, the initial rates of reaction were determined 
by monitoring the increase in absorbance of NAD(P)H ( = 6.22 mM-1 cm-1) at 340 nm.  Initial 
rates were measured at 25 °C using a Varian Cary UV 100 Bio UV-visspectrophotometer.  
Reactions were initiated by addition of ~1-20 g purified LAD enzyme with N-terminal His6tag.  
Enzyme concentrations were determined with the Bio-Rad Protein Assay (Bio-Rad, Hercules, 
CA) with bovine serum albumin (Sigma, St. Louis, MO) as standard.  For determining kinetics, 
L-arabinitol or NAD(P)
+ 
concentrations were varied from below the Km value to at least 5-times 
higher than the Km value, with saturating concentrations of the other substrate/cofactor present.   
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The Michaelis-Menton equation was fitted to the data using the non-linear curve fitting with least 
squares regression analysis in OriginPro 8 (OriginLab Corporation, Northampton, MA) to 
determine kcat and Km values. 
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CHAPTER 4 – Application of an Engineered Fungal Pathway for Xylitol 
Production from Hemicelluosic Sugars L-Arabinose and D-Xylose 
4.1.  Introduction 
While there are numerous strategies that have been developed to convert D-xylose to xylitol (see 
Chapter 1), there have been very limited number of reports on converting L-arabinose to xylitol 
in literature, as the major focus tends to be towards conversion of both D-xylose and L-arabinose 
to biofuels and other alternative value-added chemicals.  To the best of our knowledge, only one 
report by Sakakibara et al. described the development of a novel pathway for bioconversion of L-
arabinose to xylitol
1
.  The three-enzyme pathway consisted of three reactions: isomerization of L-
arabinose to L-ribulose by L-arabinose isomerase from E. coli (AraA), epimerization of L-
ribulose to L-xylulose by D-psicose 3-epimerase from Rhizobium radiobacter (DPE), and 
reduction of L-xylulose to xylitol by an NADH-dependent L-xylulose reductase from 
Ambrosiozyma monospora (LXR).  When this pathway was expressed under the control of PBAD 
promoter in an E. coli strain deficient in L-arabinose degradation, the xylitol yields were 0.72 g/g 
initial arabinose, and 0.95 g/g consumed L-arabinose.  Low amounts of ribitol (1.0 g/L) and L-
arabinitol (0.1 g/L) were also produced from initial concentration of 20.1 g/L L-arabinose.  
However, in order for the pathway to efficiently produce xylitol, a co-substrate glycerol was 
necessary to regenerate the NADH used by the LXR enzyme.  In addition, the pathway could not 
incorporate D-xylose conversion to xylitol, although the authors hinted that they were attempting 
to incorporate a separate pathway involving xylose isomerase (XylA), to convert D-xylose to D-
xylulose, followed by xylitol dehydrogenase, to convert D-xylulose to xylitol, while deleting 
endogenous xylB to prevent xylose assimilation in their pathway expressing strain. 
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In this chapter, we discuss how the application of an NADP
+
-dependent L-arabinitol 4-
dehydrogenase (LAD) in the bioconversion of xylose and arabinose to xylitol improves the flux 
towards desired product over the wild-type pathway using an NAD
+
-dependent LAD.  In 
addition, the effects of altering pentose sugar and co-substrate concentrations and the detrimental 
effect of acidic pH are discussed.  This work represents the first example of an engineered, 
entirely fungal-derived system for xylitol production from both xylose and arabinose sugars 
present in hemicellulosic hydrolysates.  Further optimization is necessary to improve 
productivity, and these issues will be addressed. 
4.2.  Results 
4.2.1.  Strain Development 
In order to effectively compare the wild-type vs. the engineered xylitol pathway, a couple of 
necessary characteristics of the expression strain were: (1) the ability to uptake pentose sugars as 
well as co-substrate simultaneously, and (2) the inability to assimilate xylose or arabinose to 
prevent shuttling pentose substrates to biomass or undesired products. 
The co-utilization of both pentose sugars along with co-substrate sugar, in this case D-glucose, to 
regenerate NADPH cofactor was first addressed.  As a result of cyclic AMP receptor protein 
(CRP)-dependent control of xyl genes
2
, E. coli exhibits diauxic growth characteristics such that 
glucose is preferentially assimilated before xylose
2-5
.  Catabolite repression refers to the 
phenomenon in which the transcription of sensitive operons is reduced by certain carbon sources 
in the medium, most prominently by glucose (‗glucose effect‘).  E. coli exhibits diauxic growth 
in sugar mixtures due to CRP-mediated catabolite repression and inducer exclusion related to 
phosphotransferase system enzyme activity.  Replacement of the native crp gene with a 
81 
 
catabolite repression mutant (referred to as crp*) enables co-utilization of glucose and other 
sugars in E. coli
6-8
.  With these desired properties satisfied, the mutant crp* was incorporated 
into the xylitol expression strain presented in this work. 
In xylose metabolism by E. coli, the bacterial xylAB operon consists of two genes; xylA (D-
xylose isomerase) and xylB (D-xylulokinase).  These genes encode for enzymes that convert D-
xylose to D-xylulose and D-xylulose to D-xylulose-5-phosphate, respectively.  The deletion of the 
xylA gene was performed using the  red system9, such that the resultant xylitol pathway 
expression strain could not use D-xylose as a carbon source for growth, leaving any internalized 
D-xylose substrate available for xylitol production.  This strain was constructed by Nikhil Nair 
using the crp* mutant strain as the parent, and was labeled as HZ1450.  The presence of the xylB 
gene was later determined not be to a major issue, as the deletion of xylA resulted in a polar 
effect that dramatically lowered XylB activity to levels such that expression of xylA on a multi-
copy plasmid could not complement the xylA deletion and restore cell growth on D-xylose (see 
Chapter 5). 
The bacterial araBAD operon consists of three genes; araB (L-ribulokinase), araA (L-arabinose 
isomerase), and araD (L-ribulose-5-phosphate 4-epimerase).  These genes encode for enzymes 
that convert L-arabinose directly to D-xylulose 5-phosphate through L-ribulose and L-ribulose 5-
phosphate.
10
  The deletion of the araBAD operon was performed using the  red system9, such 
that the resultant xylitol pathway expression strain would not be able to use L-arabinose as a 
carbon source for cell growth, leaving any internalized L-arabinose substrate available solely for 
xylitol production.  The final strain used in the expression of all xylitol constructs (C600 crp* 
xylA araBAD) was named HZ1173. 
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4.2.2.  Operon Design 
The xylitol pathway that is required to perform this bioconversion is also composed of three 
enzymes; xylose reductase (XR), L-arabinitol dehydrogenase (LAD), and L-xylulose reductase 
(LXR).  Therefore, it was strategized to design the xylitol operon after the araBAD operon 
structure, with the same promoter region, intergenic regions between the 1
st
 and 2
nd
 and between 
the 2
nd
 and 3
rd
 genes, and neglect the terminator region which would already be present in the 
expression vector chosen as the backbone.  However, one difference from the araBAD structure 
was implemented in the xylitol operon, and that was the order of the genes involved.  Typically, 
the first gene of an operon is translated and expressed the most of all the genes in the operon.  
There are concerns that ncLAD-wt (or ncLAD-3x for the engineered pathway) is the rate limiting 
enzymatic step due to the accumulation of L-arabinitol in most L-arabinose utilizing species, 
which may be due to enzyme expression, kinetics compared to the other pathway enzymes, its 
pH optimum falling in the basic pH range when intracellular pH is typically neutral to acidic, 
etc..  Therefore, LAD was placed first in the operon, followed by LXR, and lastly XR, which had 
the highest activity towards its substrates than the other enzymes. 
The final design of the xylitol operon is illustrated in Figure 4.1a, and consisted of the following 
placed in order; (1) the araBp promoter, (2) ncLAD-wt gene for the wild-type pathway operon or 
ncLAD-3x gene for the engineered pathway operon, (3) intergenic region 1 (linkBA), (4) the 
anLXR gene, (5) intergenic region 2 (linkAD), and finally, (6) the XR gene.  The operons were 
digested with NsiI and EcoRI sites that had been designed into the flanking primers, and ligated 
into pTrc99a digested with the same restriction enzymes (Figure 4.1b).  The constructs were 
verified to be correct by restriction digest and colony PCR amplification of the genes of the 
83 
 
operon, and wild-type and engineered versions containing NAD
+
-dependent LAD and NADP
+
-
dependent LAD respectively, were transformed into HZ1173. 
 
 
 
Figure 4.1.  (a)  Operon map of the xylitol pathway.  (b)  Vector map of the expression plasmid 
containing the xylitol operon.  Two versions were created, with ncLAD represented by either the 
AD
+
-dependent wild-type N. crassa LAD or engineered NADP
+
-dependent N. crassa LAD 
described in Chapter 3. 
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The resulting strains were designated as HZE2 (with wild-type xylitol synthesis operon 231-wt) 
and HZE3 (with engineered xylitol synthesis operon 231-3x).  When the strain were grown and 
induced with 1% L-arabinose for four hours at 30 °C and analyzed by SDS-PAGE, the levels of 
LAD were highest, followed by LXR, and little detection of XR was visible (Figure 4.2).  While 
the absence of XR expression from the gel staining was alarming at first, the activity check with 
cell lysates verified that XR activity was present over a negative control lysate from a strain with 
only empty vector. 
 
Figure 4.2.  SDS-PAGE analysis of xylitol synthesis pathway expressing strains.  HZE1 = 
HZ1173 + pTrc99a empty vector.  HZE2 = wild-type pathway expression strain.  HZE3 = 
engineered pathway expression strain.  Only soluble fractions of cell lysates are shown. 
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4.2.3.  Shake Flask Studies 
4.2.3.1.  Effect of Using Glucose as Co-Substrate and pH on Xylitol Production 
In using glucose as the co-substrate for xylitol production, the glycolysis rate at high sugar 
concentrations often exceeds respiratory capacity, leading to build-up of intermediate 
metabolites.  In E. coli, this results in the accumulation of acetate, leading to an acidic 
environment that results in decreased growth rates as well as lowered recombinant protein 
production.  Previous work in a similar crp* strain showed that at 18 g/L glucose concentration, 
the acetate production is significant, accumulating up to 70 mM.
11
  When HZE3 was grown in 30 
g/L glucose and 10 g/L arabinose, the pH dropped to 5.1 within 24 hours, and growth was 
inhibited.  Further initial studies attempting xylitol production resulted in minimal xylitol 
production by the wild-type strain (HZE2) and engineered strain (HZE3) (data not shown). 
As discussed in Chapter 2, the three enzymes involved in the pathway for conversion of L-
arabinose to xylitol have very different pH profiles.  This raises the concern that the optimal 
activity of LAD is around pH 9.0-9.5, with a significant decrease in activity found at pH 6.8 
(~20% maximum activity), which is the reported intracellular pH of E. coli
12
.  While it was 
reported that there exists an intracellular pH homeostasis in E. coli that serves to keep the 
intracellular pH at a relatively constant level regardless of external pH
13
, a shift in so much as 
half of a pH unit around physiological pH could drastically affect the LAD activity. 
Bioreactors are typically pH-controlled in order to allow for high cell densities to be reached.  
However, pH-control by acid or base addition during shake flask experimentation is not possible 
aseptically.  Therefore, flask studies were then run which incorporated the addition of a buffering 
component (MOPS) to the media in an attempt to offset the acetate buildup and allow for 
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improved cell growth and potentially xylitol production.  As shown in Figure 4.3, the 
extracellular pH dropped dramatically in cultures containing 2% or more glucose, while pHext 
remained relatively constant at pH 7.2 for 1% glucose.  The final cell densities also increased 
with increasing buffering capacity.  Therefore, 1% glucose was chosen as the amount used in 
further shake flask studies.  
 
Figure 4.3.  Effect of glucose concentration on extracellular pH and OD600 of cultures of HZE3.  
3% glucose, squares; 2% glucose, circles; 1% glucose, triangles.  pHext values shown in filled 
symbols, OD600 shown in empty symbols. 
 
4.2.3.2.  Wild-type vs. Engineered Xylitol Pathway 
Cultures of HZE2 and HZE3 were compared in M9 + tryptone media with 100 mM MOPS 
added as a buffering component.  Glucose was added in excess of 3:1 (w/v).  As shown in Figure 
4.4, both pathways consumed all glucose and arabinose in 20 hours.  However, the wild-type 
pathway showed xylitol production up to ~10 mM after 33 hours (approximately 50% molar 
yield from L-arabinose) whereas the engineered pathway showed minimal production with less 
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than 1 mM (<5% molar yield) xylitol produced after 56 hours.  One possible explanation for the 
slower xylitol production in the engineered pathway is the inherent 10-fold reduced affinity for 
ncLAD-3x for substrate L-arabinitol (see Chapter 3).  The maximum amount of L-arabinitol that 
can be formed is equal to the starting L-arabinose concentration (~20 mM), which is close to the 
Km,arabinitol value for ncLAD-wt (16 mM), but much less than ncLAD-3x (Km,arabinitol = 292 mM). 
Unfortunately, the amount of starting arabinose is limited in flask studies due to the fixed 1% co-
substrate glucose level restraint in order to keep the media properly buffered and prevent acetate 
accumulation and resultant pH drop.  It was found that adding more arabinose while keeping a 
constant 1% glucose concentration results in insufficient conversion of arabinose (data not 
shown).  In order to test whether L-arabinose levels were limiting, the pathways were compared 
in pH-controlled bioreactors. 
 
Figure 4.4.  Xylitol production profiles from substrate L-arabinose with glucose co-substrate in 
shake flasks.  (A) Wild-type xylitol pathway and (B) Engineered xylitol pathway. 
 
 
 
88 
 
4.2.4.  Bioreactor Studies 
4.2.4.1.  Wild-Type vs. Engineered Pathway 
Figure 4.5 shows the xylitol production profiles from 0.4 L batch controlled bioreactor cultures 
in M9 media + tryptone supplemented with 20 g/L glucose and 20 g/L L-arabinose using strain 
HZE2 (Fig. 4.5A) and HZE3 (Fig. 4.5B).  Media was maintained at pH 7.0 by automatic addition 
of 5 N NaOH.  After depletion of the initial glucose, additional glucose was added from a sterile 
60% stock.  Although residual arabinose was still left in the media, the wild-type pathway 
showed generation of L-arabinitol (up to 25 mM) and xylitol (up to 13 mM) only until ~50 hours 
and then the conversion is stalled.  The engineered pathway containing the NADP
+
-dependent 
LAD, however, shows slow yet steady conversion of L-arabinose to L-arabinitol (up to 50 mM) 
and finally to xylitol (up to 30 mM) over the course of the time prior to glucose addition at 96 
hours.  After the glucose spiking at 96 hours, both strains continued to produce L-arabinitol and 
xylitol, although the wild-type pathway did so at a modest rate compared to the engineered 
pathway. 
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Figure 4.5.  Comparison of 0.4 L (working volume) fermentation profiles for (A) HZE2 and (B) 
HZE3.  The initial culture contained 2% glucose and 2% arabinose in minimal media + tryptone.  
Additional glucose was added at the 96 hour mark.  pH was controlled at 7.0. 
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Figure 4.6 shows the results of comparing the wild-type xylitol pathway vs. engineered xylitol 
pathway in M9 + tryptone media supplemented with 3% glucose:1% arabinose.  The higher ratio 
of cosubstrate:substrate resulted in full conversion of arabinose after two days, and also resulted 
in different product profiles than when using an equal weight percent ratio.  The wild-type xylitol 
pathway (Figure 4.6A) showed xylitol production for two days, but then xylitol concentration 
began to decrease afterwards while the arabinitol concentration continues to increase.  The 
engineered pathway (Figure 4.6B) showed conversion of arabinose to arabinitol within two days, 
and slowly afterwards the xylitol accumulation began to increase with decreasing arabinitol. 
 
Figure 4.6.  Comparison of 0.4 L (working volume) fermentation profiles for (A) HZE2 and (B) 
HZE3.  The initial culture contained 3% glucose and 1% arabinose in minimal media + tryptone.  
pH was controlled at 7.0. 
 
Further analysis of the samples is necessary to determine whether the arabinitol peak detected, 
particularly after xylitol production begins, is either the L-arabinitol enantiomer or possibly the 
D-arabinitol enantiomer.  LAD has low activity with xylitol (see Chapter 2) for conversion to D-
xylulose, and LXR or another endogenous reductase could conceivably convert D-xylulose to D-
arabinitol, although this activity has not been measured with LXR in vitro.  In case the xylitol 
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was converted to D-xylulose and then to D-xylulose-5-phosphate by xylB, which was not deleted 
in the expression strain, it would be taken up into the pentose phosphate pathway and used for 
biomass production.  However, the OD600 of the cultures did not deviate after glucose was 
consumed (data not shown), and it was verified by testing growth of the strains on minimal 
media plates supplemented with arabinose that neither HZE2 nor HZE3 could grow, which 
indicated that the endogenous pathways were indeed removed and that the xylitol concentration 
decrease seen in the wild-type pathway (Figure 4.6A) is not due to conversion to D-xylulose and 
subsequent conversion to D-xylulose-5-phosphate by xylB.  It is worth noting that negligible 
xylulose was found in the cultures during the experimental run in both cases, indicating LAD is 
still a limiting conversion step in the xylitol production process from L-arabinose.  Also 
unfortunate is that xylitol production in this case was faster and of higher yield in the wild-type 
pathway than in the engineered pathway.  It is difficult to ascertain why this result occurred.  
One possible explaination is the decrease in expression levels of ncLAD-3x in HZE3 compared 
to ncLAD-wt in HZE2 (Figure 4.2).  Another possibility is the apparent decrease in affinity of 
ncLAD-3x for substrate arabinitol compared to the wild-type enzyme (see Chapter 3).  To test 
whether a higher arabinose concentration would overcome the reduced affinity, an attempt at 
xylitol production in a bioreactor setting with 4% arabinose was attempted, but results were 
inconclusive due to cultures stalling production in both strains after 24 hours prior to sugar 
addition, and another run could not be completed by the submission deadline for this disseration.  
Further optimization of this process is apparent, utilizing both buffered flasks studies combined 
with pH controlled bioreactor runs, to determine the proper conditions for optimal xylitol 
production and the effects of the cofactor balancing. 
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4.2.4.2.  Engineered Xylitol Pathway – pH control vs. non-pH control 
Figure 4.7 shows the profile of HZE3 when run in a bioreactor without pH control (Fig. 4.7A) 
and with pH control (Fig. 4.7B).  Starting levels of glucose were 2% and arabinose was 
decreased to 1% in an attempt to fully convert L-arabinose at least to L-arabinitol, and this 
purpose was served in the pH controlled run.  As seen from the uncontrolled profile, within 24 
hours cells cease to grow and L-arabinose conversion as well as glucose consumption is halted.  
L-arabinitol accumulates to ~16 mM, but no xylitol production is seen during the course of the 
fermentation.  When pH control is applied, cell density reaches a much higher level (OD600 ~13), 
and L-arabinose if fully converted to L-arabinitol within 36 hours, where xylitol production is 
starting to be noticed.  L-arabinitol is slowly converted to xylitol (up to 24 mM) until the end of 
the reactor run, but is never fully converted nor do levels drop below that of xylitol.  While 
optimization of the xylitol pathway is still an issue in terms of productivity, the effect of the pH 
control is dramatic and the engineered pathway continued to show steady xylitol production from 
L-arabinose. 
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Figure 4.7.  Comparison of 0.4 L (working volume) fermentation profiles for (A) uncontrolled 
and (B) pH-stat controlled HZE3 @ pH 7.0.  The initial culture contained 2% glucose and 1% 
arabinose in minimal media + tryptone. 
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4.2.4.3.  WT vs. ENGR Pathway – Co-utilization 
As shown in Figure 4.8, the extension of the fungal xylitol pathway for co-utilization of pentose 
sugars xylose and arabinose resulted in a similar effect seen in the arabinose only fermentations.  
Similar to the effect seen in the flask experiments and arabinose-only fermentation, the wild-type 
pathway (Figure 4.8A) again showed a halting of xylitol production after 48 hours, while the 
engineered pathway (Figure 4.8B) again showed slow yet steady production of xylitol from L-
arabinitol. 
 
Figure 4.8.  Comparison of 0.4 L (working volume) fermentation profiles for co-utilization of 
xylose and arabinose by (A) HZE2 and (B) HZE3.  The initial culture contained 3% glucose, 
0.5% xylose, and 0.5% arabinose in minimal media + tryptone.  Cultures were run at 30 °C, pH 
7.0.  
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4.3.  Discussion 
In this work, we have studied the possibility of developing a more efficient pathway for xylitol 
production from L-arabinose and D-xylose, the two major components of hemicellulosic biomass 
hydrolysates.  The pathway consists of three reactions, the first of which, xylose reductase, 
catalyzes the reduction of D-xylose directly to the desired product xylitol, and also converts L-
arabinose to L-arabinitol.  L-arabinitol is subsequently converted to L-xylulose by L-arabinitol 4-
dehydrogenase and finally to xylitol by L-xylulose reductase.  However, the reductases catalyze 
preferentially NADPH-dependent reactions, whereas the dehydrogenase is strictly NAD
+
-
dependent.  Therefore, the xylitol pathway is redox imbalanced and the cellular metabolism is 
relied on to regenerate the cofactors in order to enhance flux towards product xylitol.  In an 
attempt to alleviate the burden placed upon the cell to regenerate NADP
+
 and NADH, it was 
proposed to engineer the LAD enzyme to be NADP
+
-dependent (as discussed in Chapter 3), 
which consolidates the xylitol pathway to a single cofactor pair, NADP(H).  This effectively 
reduces the cell metabolism‘s workload to only be needed to regenerate NADPH, which can be 
accomplished through either the pentose phosphate pathway or citric acid cycle with the addition 
of an appropriate co-substrate, in this case D-glucose.   
In order to test the effects of utilizing an NADP
+
-dependent LAD in an engineered xylitol 
pathway, E. coli was chosen as a suitable host organism.  E. coli is an ideal organism for 
industrial production of chemicals due to its ability to assimilate both hexose and pentose sugars, 
rapid growth rates, ease of manipulation, and inexpensive growth medium requirements
14
.    
Most E. coli strains (including K-12) can uptake D-xylose and L-arabinose, but do not naturally 
synthesize or metabolize xylitol.  However, E. coli will grow readily on pentose sugar substrates 
D-xylose and L-arabinose, and it has been previously established that xylitol production by 
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introduction of heterologously expressed enzymes that convert D-xylose to xylitol is severely 
limited when endogenous pathways for D-xylose utilization are present.  In order to prevent the 
assimilation of pentose sugars by the pathway-expressing strain, the endogenous pathway genes 
for D-xylose (xylAB) and L-arabinose (araBAD) utilization were deleted. 
For the engineered pathway, even though the NADP
+
-dependent LAD enzyme partially relieves 
the cofactor imbalance, there are still an odd number of enzymes involved in the conversion of 
either D-xylose or L-arabinose to xylitol, so regeneration of NADPH is still necessary by the 
cell‘s metabolism.  NADPH can be regenerated by the pentose phosphate pathway and the citric 
acid cycle when using co-substrate D-glucose.  However, due to catabolite repression effects of 
using glucose with other sugars, the expression strain needed to be tailored to utilization these 
sugars simultaneously.  Different strategies of catabolite de-repression for the co-utilization of 
the glucose, xylose, and arabinose were tested by Nikhil Nair in the Zhao laboratory.  He found 
that incorporation of a mutant cyclic AMP-independent receptor protein (CRP*) showed 
efficient simultaneous assimilation of all three sugars, although xylose was shown to be the 
slowest
15
.  For all experiments run for conversion of L-arabinose to xylitol in this chapter, the 
simultaneously consumption of glucose, arabinose, and/or xylose was confirmed using a crp* 
expression strain. 
The effect of engineering and NADP-dependent LAD for use in the xylitol production pathway 
varied depending on the reaction conditions.  In bioreactor runs involving L-arabinose 
conversion alone with equal weight percent co-substrate glucose (Fig. 4.4) as well as co-
utilization of D-xylose and L-arabinose (Fig. 4.6), it appeared the engineered pathway was better 
suited for xylitol production.  Whereas the wild-type pathway experienced stalling of xylitol 
production, the engineered pathway with improved cofactor balancing showed slow yet continual 
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production of xylitol from the accumulated L-arabinitol.  However, when monitoring the 
conversion more closely with flask studies, there appears to be an initial generation of xylitol in 
the wild-type pathway followed by conversion of xylitol to an unknown by-product.  The xylitol 
conversion was not noticeable in the engineered pathway experiments, but the reactions were not 
carried out past five or six days and it is possible that the reaction is simply slower and the 
xylitol conversion does not occur until later in the reaction.  Further analysis of the samples is 
currently being conducted to determine if the by-product is D-arabinitol, which could not be 
separated from L-arabinitol by the HPLC method used to detect all sugars in the culture broth.  
There were no detectable amounts of accumulating L-xylulose in the fermentation broths, which 
suggests that the LXR reaction is not limiting in xylitol formation and that LAD is still likely the 
bottleneck in the process.  Fermentation with both D-xylose and L-arabinose as substrates 
showed full conversion of xylose to xylitol and arabinose to arabinitol, with slow steady 
conversion of arabinitol to xylitol in the engineered pathway compared to conversion of xylitol 
to an unknown byproduct in the wild-type pathway, as seen with buffered flask studies and 
arabinose-only fermentation. 
The effect of pH-stat control is illustrated strongly in Figure 4.5.  Without addition of base to 
counter the acetate production, cell growth halted after 24 hours and stayed around OD600 levels 
of ~5.5 to 6.0.  Low levels of L-arabinitol (~16 mM) were produced in the first 24 hours, but all 
xylitol pathway production shut down after this point and no xylitol was produced.  In contrast, 
utilizing a pH-stat to keep levels at pH 7.0 resulted in enhanced growth of the expression strain, 
resulting in more than twice the amount of biomass produced.  L-arabinose was fully converted 
the first enzyme, XR, to L-arabinitol within 24 hours and xylitol production was noticed after 48 
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hours.  L-arabinitol was then slowly converted to xylitol for the remainder of the bioreactor run, 
although the process did not go to completion within 162 hours. 
4.4.  Conclusions and Outlook 
This chapter illustrated the application of a fungal L-arabinose pathway for co-utilization of D-
xylose and L-arabinose for xylitol production.  While this represents a novel route of xylitol 
biosynthesis, the potential added benefit of introducing an engineered NADP
+
-dependent LAD 
from Chapter 3 to attempt to alleviate the cofactor imbalance inherent in the pathway is not yet 
established.  There remain unsolved issues with low productivity that requires further 
optimization of the pathway.  Also, the depletion of xylitol in the wild-type pathway has yet to 
be elucidated, and work is currently investigating whether byproduct D-arabinitol is 
accumulating instead, which could lead to a novel biosynthetic route to a different sugar alcohol 
than what was originally intended.  Regardless, this groundwork represents an excellent strategy 
for improving utilization of both pentose sugars present in hemicellulosic materials for synthesis 
of value-added product xylitol.  Chapter 5 will discuss work dedicated towards extending this 
engineering strategy for further downstream products attainable by fermentation of pentose 
sugars such as bioethanol. 
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4.5.  Materials and Methods 
4.5.1.  Materials 
Escherichia coli C600 was kindly provided by the Coli Genetics Stock Center (CGSC, Yale 
University).  Plasmid pTrc99a was obtained from Amersham Biosciences.  Restriction enzymes, 
NsiI and EcoRI, T4 DNA Ligase, and Phusion DNA polymerase were purchased from New 
England Biolabs (NEB, Beverly, MA).  All media components were purchased from Becton-
Dickinson (BD, Sparks, MD).  Oligonucleotide primers were purchased from Integrated DNA 
Technologies (IDT, Coralville, IA).  All DNA purification kits were obtained from Qiagen 
(Valencia, CA).  Wizard Genomic DNA Purification Kit was purchased from Promega 
(Madison, WI).  Cells were maintained on Luria-Bertani (LB) plates containing 1.5% agar and 
the appropriate antibiotic. 
4.5.2.  Gene Deletion (Notebook #3, p. 127) 
For xylitol production, E. coli K-12 C600 derivative strains were used.  Deletions were 
performed using the  red system.9  Briefly, PCR product containing cat flanked by FRT (Flp 
recognition target) and 45-50 nucleotides of sequence identical to the target locus (using forward 
primer ―H1-P1 fwd araBp‖ with sequence 5‘-AGC GGA TCC TAC CTG ACG CTT TTT ATC 
GCA ACT CTC TAC TGT GTA GGC TGG AGC TGC TTC-3‘ and reverse primer ―H2-P2 rev 
araD‖ with sequence 5‘-TTC GCC GTT GAT TTC TGC GTC GGT CAT TTT GCG GGT GCA 
GCA GTG GAA TAT GGA TAT CCT CCT TAG-3‘ in the amplification reaction) was 
transformed into cells expressing  red recombinase proteins (encoded on pKD46).  Gene 
replacement was selected on chloramphenicol plates and verified by functional assay and PCR.   
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Table 4.1.  Strains and plasmids used in this study. 
Strains/plasmids Relevant Characteristics Source/Reference 
Strains   
C600 F
-
 tonA21 thi-1 thr-1 leuB6 lacY1 glnV44  
rfbC1 fhuA1 - 
CGSC, Yale University 
ET23 Source of crp*::Tn10 Eppler and Boos, 1999 
HZ1302 C600 crp*::Tn10 Nair and Zhao, 2009 
HZ1450 C600 crp*:: Tn10 xylA Nair and Zhao, 2009 
HZ1173 C600 crp*:: Tn10 xylA araBAD This work 
HZE2 HZ1173 with pRPS231-wt This work 
HZE3 HZ1173 with pRPS231-3x This work 
   
Plasmids   
pTrc99a Amp, pBR322-derived plasmid Amersham Pharmacia 
pRPS231-wt pTrc99a with LAD-wt, XR, LXR operon under araBp 
promoter 
This work 
pRPS231-3x pTrc99a with LAD-3x, XR, LXR operon under araBp 
promoter 
This work 
 
The resistance marker was then removed by the expression of Flp recombinases from a thermo-
inducible promoter on a temperature sensitive plasmid (pCP20).  Flp recombinase plasmid loss 
and cat loss occurred simultaneously and was verified by the sensitivity to ampicillin and 
chloramphenicol.  Deletion of xylA was previously performed by Nikhil Nair, and deletion of 
araBAD was verified by PCR using cell lysates as template and appropriate flanking primers 
―Fwd minus 275 araC‖ (5‘-AAA CCA ATT GTC CAT ATT GCA TCA GA-3‘) and ―Rev araD 
stop‖ (5‘-TTA CTG CCC GTA ATA TGC CTT CGC GC-3‘).  It should be noted that araB and 
araA were fully deleted, while araD was truncated to avoid any possible downstream conflicts of 
the araBAD operon. 
4.5.3.  Mutant crp* Integration 
The crp* mutant was generated by Nikhil Nair in the Zhao laboratory by P1 transduction from 
crp*-containing plasmid ET23 (obtained from Patrick C. Cirino, Penn State University) and 
selecting for Tet
R
 integrants
6
.  Verification of glucose de-repression was first done by blue/white 
screening on LB plates containing 10 g/L glucose.  Strong induction of lacZ in presence of 
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glucose indicated de-repressed phenotype.  Finally, monitoring of sugar co-utilization in shake 
flasks was used to verify de-repression. 
4.5.4.  Operon Design and Construction (Notebook #3, p. 231-234) 
Overlap extension PCR (OE-PCR)
16
 was used to construct the xylitol synthesis operons.  Operon 
231-wt consisted of the following in order: an arabinose-inducible promoter from E. coli C600 
genomic DNA (araBp), wild-type N. crassa L-arabinitol 4-dehydrogenase (ncLAD-wt), A. niger 
L-xylulose reductase (anLXR), and N. crassa xylose reductase (ncXR).  The linker region 
between E. coli genes araB and araA (10 bp) was used as the linker region between ncLAD-wt 
and anLXR, and was designed into the primers used for amplification.  The linker region 
between E. coli genes araA and araD (284 bp) was used as the linker region between anLXR and 
ncXR, and was amplified from E. coli C600 genomic DNA, with sequences listed in Table 4.3.  
All primers used for operon construction are listed in Table 4.2.  Operon 231-3x was constructed 
in a similar fashion to operon 231-wt, except that engineered N. crassa L-arabinitol 4-
dehydrogenase (ncLAD-3x) was used in place of ncLAD-wt.  Operons 231-wt and 231-3x were 
digested with NsiI and EcoRI and ligated into identical sites of vector pTrc99a with T4 DNA 
Ligase.  Ligation mixtures were transformed into DH5 and selected on Luria Broth (LB) agar 
plates supplemented with 100 g/mL ampicillin.  Colonies were inoculated into 5 mL LB 
medium supplemented with 100 g/mL ampicillin, and plasmids were isolated from the 
overnight culture using the Plasmid Miniprep Kit from Qiagen (Valencia, CA).  Plasmids 
isolated were then subjected to restriction digestion by NsiI and EcoRI, after which the reaction 
mixtures were loaded onto 1% agarose gels and checked for correct restriction digestion pattern 
by DNA electrophoresis. 
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Table 4.2.  Primers sequences used in construction of the xylitol synthesis operons.  Forward 
primer names consist of directionality, restriction site or overhang, and the name of the region 
being amplified.  For example, ―Fwd NsiI araBp‖ stands for the forward primer used to 
amplify araBp with an NsiI cut site in front of the promoter (5‘-end).  Reverse primer names 
consist of directionality, the region being amplified, and the restriction site or overhang.  For 
example, ―Rev araBp ncLAD‖ stands for the reverse primer used to amplify araBp, with a 3‘-
end overhang sequence homologous to ncLAD.  Restriction sites shown with underlines. 
Primer Name DNA Sequence (5‘→3‘) 
Fwd NsiI araBp TTGATCGGTATGCATCCGCCATTCAGAGAAGAAAC 
Rev araBp ncLAD GAAGCGCTAGAAGCCATCGTTTCACTCCATCC 
Fwd araBp ncLAD GGATGGAGTGAAACGATGGCTTCTAGCGCTTC 
Rev ncLAD-linkBA-
anLXR 
GAGGGAATGGAGATAGGCATTATCGTGTCCTTACTCCAGACTCTGGATC 
Fwd ncLAD-linkBA-
anLXR 
GATCCAGAGTCTGGAGTAAGGACACGATAATGCCTATCTCCATTCCCTC 
Rev anLXR-linkAD GTTACATACCGGATGCGGCTACTTACCGCACGGTGTATCC 
Fwd anLXR-linkAD GGATACACCGTGCGGTAAGTAGCCGCATCCGGTATGTAAC 
Rev linkAD-ncXR GAGCTTGATAGCAGGAACCATGTTGACTCCTTCGTGCCGGATG 
Fwd linkAD-ncXR CATCCGGCACGAAGGAGTCAACATGGTTCCTGCTATCAAGCTC 
Rev ncXR EcoRI AAGTCGGATCGAATTCCTAACCGAAAATCCAGAGGTTC 
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Table 4.3.  Sequences of non-gene components of xylitol synthesis operons. 
Component Sequence 
araBp 
promoter 
5‘-ccgccattcagagaagaaaccaattgtccatattgcatcagacattgccgtcactgcgtcttttactggctctt 
ctcgctaaccaaaccggtaaccccgcttattaaaagcattctgtaacaaagcgggaccaaggccatgacaaaa
acgcgtagcaaaagtgtctataatcacggcagaaaagtccacattgattatttgcacggcgtcacactttgctatg
ccatagcatttttatccataagattagcggatcctacctgacgctttttatcgcaactctctactgtttctccataccc
gtttttttggatggag-3‘ 
linkBA 5‘-ggacacgata-3‘ 
linkAD 5‘-gtagccgcatccggtatgtaacgcctgatgcgacgctgacgcgtcttatctggcctacacgctgcgattttg 
taggccggataagcaaagcgcatccggcattcaacgcctgatgcgacgctggcgcgtcttatcaggcctacg
cgctgcgattttgtaggccggataagcaaagcgcatccggcattcaacgcctgatgcgacgctggcgcgtctt
atcaggcctacacgctgcgattttgtaggccggataagcaaagcgcatccggcacgaaggagtcaac-3‘ 
 
4.5.5.  HPLC Analysis 
Glucose, xylose, arabinose, xylitol, and arabinitol concentrations were quantified using 
Shimadzu LC-20AT high performance liquid chromatography (HPLC) equipped with a low 
temperature evaporative light scattering detector (ELSD-LT).  Products were separated with a 
Bio-Rad HPX-87C column (20 L injection) with water as the mobile phase (0.2 mL/min, 85 
°C). 
4.5.6.  Shake Flask Studies (Notebook #4, p. 279) 
For shake flask studies, overnight cultures were grown at 37 °C in LB media + 100 mM MOPS 
(pH 7.4) and appropriate antibiotics.  0.5 mL of overnight cultures were inoculated into 50 mL of 
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LB media + 100 mM MOPS (pH 7.4) containing sugars (glucose, xylose, and/or arabinose) and 
appropriate antibiotics in 250 mL baffled flasks and grown at 30 °C.  Samples were withdrawn at 
various time points and measured for cell densities at OD600 using a Cary Bio 100 UV Vis 
spectrometer.  Samples were also filtered using 0.2 m syringe filters (Millipore) and analyzed 
by HPLC for sugar analysis. 
4.5.7.  Bioreactor Studies (Notebook #4, p. 158) 
For bioreactor studies, the seed culture was prepared by growing cells first on a fresh LB plate 
supplemented with 10 g/mL tetracycline and 100 g/mL ampicillin and inoculating a single 
colony into 4 mL LB media and appropriate antibiotics at 37 °C.  1 mL of saturated overnight 
culture was centrifuged at 4,000 rpm for 4 minutes and media were decanted.  Cells were 
resuspended in 5 mL sterile water and centrifuged again at 4,000 rpm for 4 minutes and water 
was decanted.  Cells were resuspended in M9 medium supplemented with 2 mM MgSO4, 0.1 
mM CaCl2, 30 g/L glucose, 10 g/L tryptone, and appropriate antibiotic(s) and grown for another 
4-5 hours at 37 °C.  The log phase cultures were then inoculated into a Multifors multiple 
benchtop bioreactor (Infors HT, Switzerland) with 0.5 L working volume containing 400 mL of 
the same M9 + tryptone medium with additional 10 g/L each of D-xylose and/or L-arabinose, as 
well as antifoam.  Bioreactors were run at 30 °C with an agitation rate of 800 rpm by dual 
Rushton impellers and a sparging rate of 0.8 L/min with sterile air .  pH was maintained at 7.0 ± 
0.1 with 5 N NaOH and 2 N H2SO4. Samples were withdrawn at various time points and 
measured for cell densities at OD600 using a Cary Bio 100 UV Vis spectrometer.  Samples were 
also filtered using 0.2 m syringe filters (Millipore) and analyzed by HPLC for sugar analysis. 
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CHAPTER 5 – Fungal Arabinose Pathway Complementation Towards 
Determining Limitations in Arabinose Utilization 
5.1.  Introduction 
Lignocellulosic biomass is regarded as a highly promising feedstock for a rapidly expanding 
biofuels industry in response to a pressing energy problem
1
.  Lignocellulose refers to plant 
biomass that is composed of cellulose (long-chain homopolymers of D-glucose), hemicellulose 
(branched polysaccharides mainly consisting of pentose sugars D-xylose and L-arabinose), and 
lignin (complex cross-linked macromolecules).  The majority of lignocellulosic materials 
consists of D-glucose (~30-50%) and D-xylose (~20-25%), but L-arabinose is still a significant 
third portion in some forms of lignocelluose (~ 5-10%)
2,3
.  Utilization of all sugars in the raw 
material is favored for an economically competitive process. 
Yeast cells are particularly attractive for cellulosic ethanol processes because they have been 
used in biotechnology for hundreds of years, are well-characterized physiologically and 
genetically, have ample genetic tools, are tolerant to high ethanol and inhibitor concentrations, 
and can grow at low pH values which avoids bacterial contaminations.  Unfortunately, the 
widely used industrial yeast Saccharomyces cerevisiae cannot metabolize the pentose sugars D-
xylose or L-arabinose found in hemicellulose.  S. cerevisiae naturally harbors genes for xylose 
utilization, but they are expressed at such low levels that they do not support growth on D-
xylose
4
.  A large number of yeast species metabolize D-xylose and L-arabinose and display 
fermentative ability, but only approximately 1% of them are capable of fermenting D-xylose to 
ethanol
5
.  Various yeasts and fungi were initially screened to evaluate their ability to ferment L-
arabinose under oxygen-limited conditions when grown in defined minimal media containing 
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mixtures of L-arabinose, D-xylose, and D-glucose
6
.  Although all of the yeasts and some of the 
fungi consumed L-arabinose, L-arabinose was not fermented to ethanol by any of the strains 
tested.  L-Arabinitol was the only major product other than cell mass formed from L-arabinose.  
The inability to ferment L-arabinose was postulated to be a consequence of inefficient or 
incomplete assimilation pathways for this pentose sugar.  A subsequent study identified four 
yeast species able to ferment L-arabinose to ethanol
7
, but the discrepancy was likely due to the 
use of complex (YP) medium that could have contained compounds that may act as electron 
acceptors and thus aid conversion of arabinose to ethanol
5
. 
Pathways for D-xylose and L-arabinose metabolism share a common intermediate in the form of 
D-xylulose-5-phosphate, but are distinctly different in bacteria and fungi.  Bacterial catabolism of 
D-xylose and L-arabinose begins with isomerization to D-xylulose and L-ribulose, respectively, 
by an isomerase.  D-xylulose and L-ribulose are phosphorylated by a xylulokinase to D-xylulose-
5-phosphate and to L-ribulose-5-phosphate, respectively, with the latter being converted by an 
epimerase to D-xylulose-5-phosphate and connecting the initial pentose metabolism to the central 
metabolism through the pentose phosphate pathway (PPP).  The yeast pathway has been 
previously described (Figure 1), and has been more successful in its implementation due to 
troubles getting functional bacterial enzymes in S. cerevisiae. 
Many metabolic engineering strategies have been attempted to improve fermentation of D-xylose 
to ethanol in recombinant S. cerevisiae harboring D-xylose-utilization enzymes.  These include 
over-expression of endogenous xylulokinase
8
, glyceraldehydes-3-phosphate dehydrogenase
9
, 
transaldolase and transketolase, or deletion of glucose 6-phosphate dehydrogenase
10
.  Alternative 
protein engineering strategies aimed at the cofactor imbalance of the initial pathway enzymes has 
also been pursued, by introducing NADH-preferring XR mutants
11,12
, or NADP-dependent XDH 
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mutants
13,14
.  However, these cofactor balancing strategies have only been dedicated towards 
xylose fermentation. 
The fermentation of L-arabinose to ethanol has only recently been established in S. cerevisiae, 
with reports of the introduction of the bacterial pathway 
15,16
 , or the fungal pathway
17,18
 showing 
promising progress in the field of L-arabinose utilization by S. cerevisiae, but yields of ethanol 
using either strategy have been low.  Co-utilization of D-xylose and L-arabinose has also been 
shown to occur with fungal D-xylose and bacterial L-arabinose pathways introduced into S. 
cerevisiae 
5,19
, but most of the L-arabinose was converted to byproduct L-arabinitol by the fungal 
xylose reductase.  During the course of the work presented in this thesis, Bettiga et al. expressed 
an engineered fungal L-arabinose pathway into S. cerevisiae and achieved anaerobic biomass 
production and ethanol production.  The pathway combined i) an engineered mutant XR with 
increased NADH perference; ii) a NAD
+
-dependent LAD from Trichoderma reesei (Hypocrea 
jecorina); iii) a NADH-dependent LXR from Ambrosiozyma monospora and iv) a NAD
+
-
dependent XDH from Pichia stipitis.  The resultant pathway was cofactor balanced by 
consolidating the initial pathway enzymes to the alternative cofactor pairing, NAD(H), whereas 
my research focused on using a pathway designed for NADP(H).  Expression of the Bettiga 
pathway in their strain TMB3043 was chosen as background since it has been endowed with 
genetic modifications allowing for improved pentose fermentation, such as overexpression of 
PPP and XKS. In addition, TMB3043 harbors the deletion of GRE3, coding for an unspecific 
NADPH aldose reductase.  The removal of the Gre3p NADPH-dependent activity contributes to 
a more cofactor balanced pentose utilizing pathway.  The final ethanol concentration was 9.3 g/l, 
with a yield of 0.21 g/(g sugar) based on total sugars present at the beginning of the 
fermentation, 0.42 g/(g sugar) based on consumed sugars and 0.35 g/(g sugar) based on 
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consumed L-arabinose.  While this strategy represented an almost 10-fold improvement over the 
previous reported values
17
, clearly much progress is still needed in this area to make the process 
more efficient and economically feasible. 
The proposed pentose utilization project deals with utilizing L-arabinose in combination with D-
xylose for the production of ethanol.  The initial sequence of four alternating reduction and 
oxidation steps in L-arabinose catabolism is potentially a rate-limiting factor in the catabolic 
sequence
20
,  as natural L-arabinose metabolizing yeasts, as well as engineered Saccharomyces 
cerevisiae, produce large amounts of L-arabinitol.  The goal of this project is to determine the 
effect of reversing the cofactor specificity for the dehydrogenases (LAD and XDH) involved in 
the fungal L-arabinose utilization pathway.  This chapter will discuss progress made in cloning 
and engineering an NADP
+
-dependent N. crassa XDH, the introduction of the full initial L-
arabinose pathway into S. cerevisiae, and the development of a selection method using E. coli to 
set the foundation for future pathway engineering. 
5.2.  Results 
5.2.1.  Cloning, Characterization, and Engineering of an NADP+-Dependent N. crassa 
Xylitol Dehydrogenase 
A putative Neurospora crassa xylitol dehydrogenase sequence was found using a protein 
BLAST search on the National Center for Biotechnology Information website 
(www.ncbi.nlm.nih.gov) using the Pichia stipitis xylitol dehydrogenase enzyme as a query 
sequence.  The two enzymes were aligned fully using a ClustalW algorithm and found to share 
44% identity and 60% similarity (Figure 5.1).  The whole-genome sequence of Neurospora 
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crassa has been published
21
, and it was utilized to design primers for cloning of the putative 
xylitol dehydrogenase gene. 
 
Score =  299 bits (765),  Expect = 3e-79, Method: Compositional matrix adjust. 
 Identities = 169/365 (46%), Positives = 222/365 (60%), Gaps = 22/365 (6%) 
 
psXDH       ANPSLVLNKIDDISFETYDAPEISEPTDVLVQVKKTGICGSDIHFYAHGRIGNFVLTKPM  62 
            +N S VLNK  D+ F+    P+I+ P DVLV V  TGICGSD+H++ HG IG+FV+  PM 
ncXDH       SNLSFVLNKPLDVCFQDKPVPKINSPHDVLVAVNYTGICGSDVHYWLHGAIGHFVVKDPM  66 
 
psXDH       VLGHESAGTVVQVGKGVTSLKVGDNVAIEPGIPSRFSDEYKSGHYNLCPHMAFAATPNSK  122 
            VLGHESAGT+V VG  V +L VGD VA+EPG P R      SGHYNLCP M FAATP    
ncXDH       VLGHESAGTIVAVGDAVKTLSVGDRVALEPGYPCRRCVHCLSGHYNLCPEMRFAATPPYD  126 
 
psXDH       EGEPNPPGTLCKYFKSPEDFLVKLPDHVSLELGALVEPLSVGVHASKLGSVAFGDYVAVF  182 
                   GTL  ++ +P DF  KLP+ VSL+ GAL+EPL+V VH +K   +  G  V V  
ncXDH       -------GTLTGFWTAPADFCYKLPETVSLQEGALIEPLAVAVHITKQAKIQPGQTVVVM  179 
 
psXDH       GAGPVGLLAAAVAKTFGAKGVIVVDIFDNKLKMAKDIGAATHTFNSKTGGSEE-----LI  237 
            GAGPVGLL AAVAK +GA  V+ VDI  +KL+ AK   AATHT+ S+    EE     +  
ncXDH       GAGPVGLLCAAVAKAYGASKVVSVDIVPSKLEFAKSF-AATHTYLSQRVSPEENARNIIA  238 
 
psXDH       KAFGGNVPNVVLECTGAEPCIKLGVDAIAPGGRFVQVGNAAGPVSFPITVFAMKELTLFG  297 
             A  G   + V++ +GAEP I+  +  +  GG +VQ G     ++FPI    +KE+T  G 
ncXDH       AADLGEGADAVIDASGAEPSIQAALHVVRQGGHYVQGGMGKDNITFPIMALCIKEVTASG  298 
 
psXDH       SFRYGFNDYKTAVGIFDTNYQNGRENAPIDFEQLITHRYKFKDAIEAYDLVRAGKGAVKC  357 
            SFRYG  DY+ A+ +         E   +D ++L+     FK+A EA+  V+ G+  +K  
ncXDH       SFRYGSGDYRLAIQLV--------EQGKVDVKKLVNGVVPFKNAEEAFKKVKEGE-VIKI  349 
 
psXDH       LIDGP  362 
            LI GP 
ncXDH       LIAGP  354 
 
Figure 5.1.  BLAST Results for putative XDH in Neurospora crassa. 
 
RT-PCR performed on total RNA isolated from D-xylose-induced N. crassa 10333 showed the 
expected size of gene product (~1.1 kb).  The RT-PCR product was cloned into the pET-28a 
vector using NdeI and SacI restriction sites and was transformed into E. coli BL21 (DE3).  This 
construct (pET-28a ncXDH) expressed N. crassa XDH as an N-terminal His6-tagged fusion with 
a thrombin cleavage site.  Cell lysates of IPTG-induced cultures of these cells were prepared, 
analyzed by SDS-PAGE, and assayed for XDH activities.  The XDH was then purified by 
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immobilized metal ion affinity chromatography (IMAC) using Talon
®
 Co
2+
 Superflow resin 
(Clontech, Mountain View, CA) according to manufacturer‘s protocol.  The purified protein was 
desalted by ultrafiltration with several washes of 50 mM 4-(2-hydroxyethyl)piperazine-1-
ethanesulfonic acid (HEPES) buffer (pH 7.25) + 15% glycerol and stored frozen at -80 °C.  
Protein concentrations were determined by the Bradford method
22
. 
ncXDH is a strictly NAD
+
-preferring enzyme.  ncXDH also displays high stability (half-life of 
~200 min at 50 C) and expression.  Previous work by Watanabe et al. was aimed at reversing 
the cofactor specificity of Pichia stipitis xylitol dehydrogenase (psXDH).
14
  Through sequence 
alignment, residues D204, I205, and V206 were targeted for site-directed mutagenesis to alanine, 
arginine, and serine, respectively, to create ncXDH-ARS.  Table 5.1 shows that ncXDH-ARS has 
completely reversed cofactor specificity, now preferring NADP
+
, with little change in the kcat 
value and only a 2.5-fold higher Km,NADP+ for ncXDH-ARS compared to the Km,NAD+ for the wild-
type.  Table 5.2 shows that the affinity for substrate xylitol did not suffer the loss that was 
previously seen in engineering an NADP+-dependent ncLAD (see Chapter 4).  It should be noted 
that the same mutations were attempted in the ncLAD engineering, but the improvement was not 
as drastic, necessitating the library screening that was implemented in Chapter 3. 
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Table 5.1.  Kinetic parameters for N. crassa and P. stipitis XDH and XDH-ARS with 
nicotinamide cofactors NAD
+
 and NADP
+
. 
 NAD
+
  NADP
+
  
Enzyme kcat 
(min
-1
) 
Km 
(mM) 
kcat/Km 
(mM
-1
 min
-1
) 
 kcat 
(min
-1
) 
Km 
(mM) 
kcat/Km 
(mM
-1
 min
-1
) 
Source 
ncXDH-wt 2160   0.127 17000  -
a
 ~5.6 ~68 This work 
ncXDH-ARS -
a
 ~3.5   ~165  2080 0.325 6400 This work 
psXDH 1050   0.381   2760  110 170 0.65 Watanabe et al. 
psXDH-ARS   240   1.3     181  2500 0.897 2790 Watanabe et al. 
a
Not determined, cofactor saturation not reached 
All assays were performed at 25 C in 50 mM Tris, pH 8.0 
 
Table 5.2.  Kinetic parameters of ncXDH mutants for substrate xylitol. 
Enzyme kcat  
(min
-1
) 
Km 
(mM) 
kcat/Km 
(mM
-1
 min
-1
) 
ncXDH-wt 2170 ± 135  6.6 ± 2.0  330 
ncXDH-ARS 2090 ± 35  4.3 ± 0.3   490 
a
Not determined, saturation of cofactor not reached 
All assays run at 25 C, 50 mM Tris-HCl pH 8.0 
All enzymes were purified and characterized with N-His6Tag 
 
As discussed in Chapter 4, the pH rate profile of N. crassa LAD in the L-arabinose pathway 
favor basic conditions, whereas it is known that the intracellular pH of E. coli
23
 or S. cerevisiae
24
 
is neutral to acidic.  The same holds true for N. crassa XDH, as shown in Figure 5.2, but XDH 
activity exhibits a higher tolerance to more acidic conditions with activity extending down to pH 
4.0, whereas LAD activity is abolished at pH 5.0 in the in vitro activity assay. 
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Figure 5.2. Comparison of pH rate profiles of N. crassa LAD and XDH.  Data taken from the 
characterization of LAD from Chapter 2 (open circles) was performed in universal buffer 
MES/Tris/glycine, and overlapped with data for ncXDH (closed triangles) and ncLAD (closed 
circles) performed in universal buffer acetic acid/MES/Tris for lower pH values. 
 
5.2.2.  Introduction of L-Arabinose Pathway into S. cerevisiae 
The initial five enzymes of the fungal L-arabinose pathway that convert L-arabinose to D-
xylulose-5-phosphate leading into the pentose phosphate pathway were constitutively expressed 
in S. cerevisiae.  The wild-type pathway was assembled with NAD
+
-dependent ncLAD-wt and 
ncXDH-wt, while the engineered pathway was assembled with NADP
+
-dependent ncLAD-3x 
(see Chapter 3) and ncXDH-ARS (see Section 5.2.1) and correctly assembled constructs were 
verified by restriction digestion with BamHI (Fig. 5.3a) and by PCR amplification of the five 
gene cassettes (Fig. 5.3b).  Strains were then grown on synthetic complete media lacking uracil 
(SC-Ura) supplemented with either glucose, xylose, or arabinose as a carbon source.  Figure 5.4 
shows that strains containing either the wild-type or engineered pathway grew readily in SC-Ura 
+ xylose, while the parent strain YSG50 could not utilize xylose.  However, neither strain was 
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found to grow in liquid SC-Ura + 2% arabinose.  There was minimal growth in solid agar plates 
with the same media over the course of 14 days. 
 
 
Figure 5.3.  Example of yeast plasmid verification. (a) Restriction digest with BamHI, where sL 
= simulated ladder, sD = simulated digest pattern, L = DNA ladder, and 1-7 digests of plasmids 
prepared from seven different colonies with 100% efficiency of correctness. (b) PCR 
amplification of gene cassettes from verified plasmid.  L = DNA ladder, 1 = XR cassette, 2 = 
XDH cassette, 3 = XKS cassette, 4 = LAD cassette, 5 = LXR cassette, (-) = negative control with 
respective cassette primers run with empty plasmid. 
 
Figure 5.4.  Growth of L-arabinose pathway expressing S. cerevisiae strains in SC-Ura + 2% 
xylose.  The WT pathway contains all wild-type L-arabinose pathway genes, while the ENGR 
pathway replaces both NAD
+
-dependent ncLAD-wt and ncXDH-wt with NADP
+
-dependent 
ncLAD-3x and ncXDH-ARS.  The control strain is YSG50 with empty plasmid pRS426. 
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5.2.3.  E. coli Complementation Experiments 
Due to the inability to get a functional L-arabinose pathway in S. cerevisiae, E. coli was chosen 
as a suitable host for the development of a selection method to determine (1) whether the fungal 
pathway would be able to complement the bacterial pathway and circumvent the issues 
associated with S. cerevisiae such as pentose transport, gene expression and protein solubility, 
potential acidic intracellular pH conditions, and transcriptional regulation, and (2) whether the 
cofactor balanced engineered pathway would result in improved growth and/or ethanol 
production.  Table 5.3 lists the strains used for xylose complementation experiments in E. coli 
MG1655.  The deletion of xylA by cat insertion was confirmed to abolish the ability of HZE60 to 
grow in minimal media supplemented with xylose.  In order to confirm that complementation 
was possible by expression of the endogenous genes under the xylAp promoter in a plasmid, 
constructs with either xylA or xylA and xylB together were transformed into HZE60 and selected 
in xylose minimal media.  As shown in Figure 5.5, over-expression of xylA alone was able to 
complement growth in xylose minimal media.  When both xylA and xylB were over-expressed, 
the strain grew faster, which suggests that the deletion of XylA activity with the cat insertion 
resulted in a polar effect that subsequently decreased XylB expression as well in HZE60.  
Table 5.3.  Strains constructed for D-xylose growth complementation experiments 
MG1655 F
-
 - ilvG- rfb-50 rph-1   (ATCC 700926) 
HZE60 MG1655 xylA::cat (obtained from Tasha Desai) 
HZE66 MG1655 xylA::cat pTrc99a 
HZE67 MG1655 xylA::cat pTrc99a-xylAp-xylA 
HZE68 MG1655 xylA::cat pTrc99a-xylAp-xylAB 
HZE101 MG1655 xylA::cat pTrc99a-xylAp-ncXDH(wt)-ncXR-xylB 
HZE102 MG1655 xylA::cat pTrc99a-xylAp-ncXDH(ARS)-ncXR-xylB 
HZE109 MG1655 xylA::cat pTrc99a-xylAp-ncXDH(wt)-ncXR-psXKS 
HZE110 MG1655 xylA::cat pTrc99a-xylAp-ncXDH(ARS)-ncXR-psXKS 
HZE123 MG1655 xylA::cat pBLMA-xylAp-ncXDH(wt)-ncXR-xylB 
HZE124 MG1655 xylA::cat pBLMA-xylAp-ncXDH(ARS)-ncXR-xylB 
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To determine whether XR and XDH together could complement XylA activity, two constructs 
were tested, containing XR and either wild-type NAD
+
-dependent XDH or engineered NADP
+
-
dependent XDH.  In Figure 5.5, the wild-type pathway under the control of xylAp with either 
xylB (HZE101) or psXKS (HZE109) was confirmed to complement growth, whereas the 
engineered pathways (HZE102 and HZE110) did not complement growth in minimal media with 
xylose.  This is contradictory to what was seen in S. cerevisiae.  However, when plated on M9 
media with 5% xylose, slow grow was noticable with the engineered pathway under the control 
of xylAp (HZE110, Figure 5.6). 
 
 
Figure 5.5. Growth complementation on M9 + 0.4% xylose at 37 °C (See Table 5.3 for legend). 
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Figure 5.6.  Growth complementation on M9 + 5% arabinose at 30 °C. (See Table 5.3 for 
legend). 
 
Table 5.4 lists the strains used for arabinose complementation experiments in E. coli MG1655.  
Again, the same control strategy was applied by knocking out endogenous araBAD, which 
resulted in the lack of cell growth in minimal media supplemented with L-arabinose, and 
expression of araBAD in the knockout strain showing complementation was achieved. 
Table 5.4.  Strains constructed for L-arabinose growth complementation experiments 
HZE62 MG1655araBAD (obtained from Tasha Desai) 
HZE71 MG1655 araBAD pTrc99a 
HZE72 MG1655 araBAD pTrc99a araBp-araBAD 
HZE103 MG1655 araBAD pTrc99a + pRSFDuet 
HZE104 MG1655 araBAD pTrc99a araBp-ncLAD(wt)-anLXR-ncXR + pRSFDuet araBp-
ncXDH(wt)-xylB 
HZE105 MG1655 araBAD pTrc99a araBp-ncLAD(3x)-anLXR-ncXR + pRSFDuet araBp-
ncXDH(ARS)-xylB 
 
However, when the wild-type (HZE104) or engineered (HZE105) fungal arabinose pathways 
were expressed in the araBAD-deletion strain, neither construct could complement cell growth 
on L-arabinose media (data not shown). 
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5.3.  Discussion 
As mentioned earlier, the wild-type L-arabinose pathway has been introduced into S. cerevisiae 
previously by Richard et al. although with little resultant ethanol production from L-arabinose.
17
  
With the first four enzymes of the L-arabinose pathway already cloned, the final enzyme, D-
xylulokinase from Pichia stipitis (psXKS) was first cloned from P. stipitis cDNA into E. coli 
prior to introduction into S. cerevisiae.  Over-expression of xylulokinase in S. cerevisiae has 
been reported to enhance specific ethanol production when grown on D-xylose
25
.  Introduction of 
the L-arabinose pathway into S. cerevisiae was accomplished by a new homologous 
recombination-based DNA assembly method developed by Zengyi Shao and Hua Zhao in the 
Zhao laboratory.
26
 
The full-length pathway placed in pRS426 was comprised of the following gene cassettes (―p‖ 
indicates promoter, ―t‖ indicates terminator sequence): ADH1p-ncXR-ADH1t, GPDp-ncLAD-
PYK1t, HXT7p-anLXR-HXT7t, PGK1p-ncXDH-CYC1t, and PYK1p-psXKS-ADH2t.  Colonies 
were selected on synthetic complete media lacking uracil (SC-Ura) with either D-xylose or L-
arabinose as the sole carbon source to confirm the pathway was functional.  Colonies formed 
readily on D-xylose after about four days, albeit slower than when compared to the typical two 
day incubation for D-glucose containing media.  The engineered pathway strain (containing the 
NADP-dependent dehydrogenases ncLAD-SRN and ncXDH-ARS) also grew on D-xylose, and 
had similar growth rate compared to the wild-type pathway.  An interesting, although 
unfortunate, observation was that while colonies were able to form on L-arabinose plates after 
~10-14 days, subsequent inoculation of these colonies into liquid SC-Ura with L-arabinose as the 
sole carbon source were unable to grow for reasons yet to be determined.  Colonies that grew up 
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on both pentose sugar plates were checked by colony PCR and restriction digestion analysis to 
confirm the pathway had been assembled properly. 
It remains unknown why S. cerevisiae grew so poorly in L-arabinose media.  Cofactor 
imbalance, one of the key areas of research in the proposed project, is thought to be one reason.  
However, transport of pentose sugars has also been brought to attention
27-29
, and this is currently 
being investigated by Jing Du and Sijin Li in the Zhao group.  Recently, strong evidence has 
shown support for the need of improvement of the LAD enzyme.  Two natural L-arabinose-
utilizing yeasts, Candida arabinofermentans PYCC 5603T and Pichia guilliermondii PYCC 
3012 were compared to gain more insights into the limitations of L-arabinose metabolism.  
13
C 
NMR was used to trace the fate of L-[2-
13
C]arabinose through branching metabolic pathways, 
and intracellular accumulation of arabinitol appeared in both strains, indicating a bottleneck at 
the level of LAD which was also NAD
+
-dependent in these strains
30
.  It is hypothesized that an 
improved ncLAD enzyme, along with cofactor reversal for the dehydrogenase enzymes for 
NADP
+
-dependence, can shed light on the utilization of pentose sugars for ethanol production.  
However, the results from expressing the fungal L-arabinose pathway in S. cerevisiae suggest 
that the cofactor imbalance alone is not the answer to obtaining a strain that can grow readily on 
L-arabinose. 
As shown in Section 5.2.4, the L-arabinose pathways were also expressed in E. coli as a model 
organism.  E. coli can grow readily in either xylose or arabinose containing media, which 
suggests it does not suffer from the possible limitations that S. cerevisiae has in pentose 
utilization.  Preliminary results have shown that the wild-type and, to a lesser extent, the 
engineered fungal xylose pathway under the control of xylAp can complement growth in M9 + 
5% xylose media at 30 °C. 
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5.4.  Conclusions 
The development of a selection method based on the complementation of E. coli pentose 
utilization genes with those of fungal origin can help to determine the bottlenecks associated 
with the initial pathway enzymes and conclude whether engineering a cofactor balanced pathway 
helps in pentose utilization.  The XDH from N. crassa was cloned, characterized, and engineered 
for NADP
+
-dependence, and the five genes that convert L-arabinose to D-xylulose-5-phosphate 
for entrance into the pentose phosphate pathway were introduced into S. cerevisiae.  
Unfortuntely, only growth on xylose was attained, with minimal growth on solid media 
containing arabinose only.  Due to potential issues involved with transport, expression, etc., the 
pathways were tested in E. coli with resultant growth only achievable on xylose and not 
arabinose.  Further optimization of the pathway expression is still required in order for the 
arabinose pathway to be functional. 
5.5.  Materials and Methods 
5.5.1.  Materials 
The Neurospora crassa genomic sequence and LAD protein sequences were accessed from the 
National Center for Biotechnology Information (NCBI, www.ncbi.nlm.nih.gov).  Neurospora 
crassa 10333 was obtained from the American Type Culture Collection (ATCC).  Escherichia 
coli BL21(DE3) and pET-28a(+) expression vector were obtained from Novagen (Madison, WI).  
SuperScript One-Step RT-PCR with Platinum Taq kit was obtained from Invitrogen 
(Carlsbad, CA).  PCR grade dNTPs were obtained from Roche Applied Sciences (Indianapolis, 
IN).  Phusion High-Fidelity DNA Polymerase, shrimp alkaline phosphatase, and DNA-
modifying enzymes DNase I, NdeI, SacI, and T4 DNA ligase and their appropriate buffers were 
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purchased from New England Biolabs (NEB) (Beverly, MA).  Xylitol, -D-
thiogalactopyranoside (IPTG), and NADP
+
 were purchased from Sigma (St. Louis, MO).  NAD
+
 
was a gift from Jülich Fine Chemicals (Jülich, Germany).  Other required salts and reagents were 
purchased from Fisher (Pittsburgh, PA) or Sigma-Aldrich.  The QIAprep spin plasmid mini-prep 
kit, QIAquick gel purification kit, RNeasy midiprep kit, and QIAquick PCR purification kit were 
purchased from Qiagen (Valencia, CA).  Oligonucleotide primers were obtained from Integrated 
DNA Technologies (Coralville, IA).  SDS-PAGE gel materials, electrophoresis equipment, and 
protein size markers were from Bio-Rad (Hercules, CA). 
5.5.2.  RT-PCR and Cloning 
N. crassa 10333 was grown on rich potato media at 30 °C for 24 h and induced with 150 mM D-
xylose for 2 hr.  Total ribonucleic acid (RNA) was purified from collected cells (RNeasy 
purification kit, Qiagen) and treated with DNase I to remove residual genomic DNA.  RT-PCR 
was performed using SuperScript™ One-Step RT-PCR with Platinum® Taq (Invitrogen) 
following the manufacturer‘s guidelines.  A control reaction consisted of the same protocol 
except for the SuperScript enzyme mix was heated to 95 ºC for ten minutes to thermally 
inactivate the reverse transcriptase enzyme and the reverse transcription thermocycler step was 
omitted.  The primers used for the RT-PCR were: forward 5′- GTA GCT ACG TCA CAT ATG 
CTA CCG ACG GCA AGT CT -3′ and reverse 5′- AGC TGA TAG CGA GCT CTT AGC AGC 
AGC CAG AAC C -3′.  The forward primer contained an NdeI restriction site (shown in bold), 
while the reverse primer contained a SacI restriction site (shown in bold) and stop codon 
(italicized).  The resulting RT-PCR product was isolated by a QIAquick agarose gel purification 
kit. The product was digested with NdeI and SacI restriction enzymes and purified again by 
agarose gel electrophoresis.  It was then ligated into pET-28a(+) which had been previously 
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prepared by NdeI and SacI digestion, dephosphorylation by shrimp alkaline phosphatase, and gel 
purification.  The ligation mixture was used to transform E. coli DH5 by electroporation.  
Positive clones were selected on Luria–Bertani (LB) solid media with ampicillin at 37 °C 
overnight.  All colonies were then removed from the plates and grown to saturation in 5 mL 
liquid LB from which the plasmids were purified using a QIAprep spin plasmid miniprep kit, 
which were used to transform E. coli BL21(DE3) by heat shock.  Positive clones were selected 
on LB solid media with ampicillin, picked individually, and assayed for XDH activity by the cell 
lysate assay described below.  Plasmids were sequenced using the BigDye
®
 Terminator 
sequencing method and an ABI PRISM 3700 sequencer (Applied Biosystems, Foster City, CA).  
Sequencing results determined at the Biotechnology Center of the University of Illinois. 
5.5.3.  Cell Lysate Assay 
E. coli BL21 (DE3) harboring the pGEX-4T-3-derived vector was grown to a maximum optical 
density at 600 nm (OD600) at 37 °C with shaking at 250 rpm. Fifty microliters was used to 
inoculate a new culture, which was grown at 37 °C with shaking at 250 rpm until an OD600 of 
~0.6 was reached.  The cultures were then induced with 0.3 mM IPTG and shaken at 250 rpm at 
25 °C for 4 h.  One milliliter of cells was harvested by centrifugation and lysed by resuspension 
in 1 mL of 1 mg/mL lysozyme/50 mM Tris-HCl (pH 8.0).  The cells were frozen at −80 °C and 
thawed at room temperature. The resulting lysate was vortexed thoroughly and centrifuged to 
remove cell debris.  Ten microliters of the lysate was used in a kinetic assay described below in 
the Enzyme Kinetics Section with 200 mM xylitol and 2 mM NAD
+
 as the substrates in 50 mM 
Tris (pH 8.0). 
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5.5.4.  Enzyme Kinetics 
Initial rates were determined by measuring the initial rate of reaction as observed by the increase 
of absorbance at 340 nm using a Varian Cary 100 Bio UV-visible spectrophotometer (Varian, 
Palo Alto, CA) at 25 °C in 50 mM Tris-HCl (pH 8.0).  N. crassa XDH and XDH-ARS kinetic 
measurements were taken with saturation of xylitol and varying cofactor NAD
+
 or NADP
+
 
concentrations or vice versa.  The data were used to calculate the kinetic constants by fitting the 
Michaelis-Menten equation using Origin 8.0.  The data represent averages of assays performed 
in duplicate or triplicate on two separate occasions. 
5.5.5.  pH Profile 
Activity was measured at pH values between 3.5 and 8.0 under saturating concentrations of 
NAD
+
 (2 mM) and xylitol (200 mM) in a universal buffer (50 mM morpholineethanesulfonic 
acid (MES) / 50 mM Tris / 50 mM glycine).  Ionic strength of the universal buffer was taken into 
consideration according to previously established buffer compositions
31
. 
5.5.6.  Pathway Construction (S. cerevisiae) (Notebook #5, p. 101) 
S. cerevisiae YSG50 (MAT ade2-1 ade322 ura3-1 his3-11,15 trp1-1 leu2-3,112 and can1-
100) was used as the host for DNA assembly.  pRS426 plasmid (New England Biolabs, Beverly, 
MA) was linearized with BamHI and XhoI restriction enzymes.  To prepare individual gene 
expression cassettes, yeast promoters (ADH1p, 1500 bp; PGK1p, 750 bp; PYK1p, 1000 bp; 
GPDp, 655 bp, and HXT7p, 395 bp), genes (ncXR, ncXDH, psXKS, ncLAD, and anLXR), and 
yeast terminators (ADH1t, 327 bp; CYC1t, 250 bp, ADH2t, PYK1t, 400 bp; HXT7t, 400 bp) 
were amplified from corresponding plasmids in the Zhao laboratory stock library.  Each 
individual gene cassette was assembled by overlap extension PCR (OE-PCR)
32
.  Following 
electrophoresis, the OE-PCR product was gel purified from a 1.0% agarose gel using Qiagen Gel 
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Purification Kit (Valencia, CA).  Each individual gene expression cassette (~300 ng) was mixed 
with linearized pRS426 and transformed into S. cerevisiae. 
5.5.7.  Yeast Transformation (S. cerevisiae) 
Yeast transformation was performed by electroporation.  YPAD medium (50 mL) was inoculated 
with a 0.5 mL overnight culture of S. cerevisiae YSG50 and incubated at 30 °C with shaking at 
250 rpm for 4-5 hours until OD600 reached 0.8-1.0.  Yeast cells were harvested by centrifugation 
at 4 °C and 4000 rpm for 5 min.  The supernatant was decanted and the cell pellet was washed 
with 50 mL cold sterile water, followed by another wash with cold 1 M sorbitol and finally 
resuspended in 250 L cold 1 M sorbitol.  An aliquot of 50 L of yeast cells together with DNA 
mixture containing linearized pRS426 vector and five gene cassettes, and electroporated in a 0.2 
cm cuvette at 1.5 kV.  The transformed cells were immediately mixed with 1 mL room 
temperature YPAD medium and shaken at 30 °C for 1 hour.  Cells were harvested by 
centrifugation, washed with room temperature 1 M sorbitol several times to remove remaining 
media, and finally resuspended in 1 mL 1 M sorbitol.  Aliquots of 30-50 L were spread on SC-
Ura plates for the selection of the transformants, and the plates were incubated at 30 °C for 2-4 
days until colonies appeared.  Colonies were randomly picked into SC-Ura liquid media and 
grown for 1 day, after which the yeast plasmid was isolated using Zymoprep II Yeast plasmid 
Miniprep kit (Zymo Research, CA), and confirmed by restriction digestion analysis and PCR. 
5.5.8.  Pathway Construction (E. coli) (Notebook #4, p. 151) 
Xylose and arabinose pathway pathway operons were amplified by overlap extension PCR (OE-
PCR).  Xylose pathway operons consisted of XDH (wild-type XDH-wt or engineered XDH-
ARS), linker BA (see Chapter 4), XR, linker AD (see Chapter 4), and xylB under the xylose-
inducible xylAp promoter.  Following electrophoresis, xylose pathway operons were digested 
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with NsiI and EcoRI and ligated into pTrc99a vector and transformed into DH5.  Plasmids were 
purified and verified by plasmid purification and digestion with respective flanking restriction 
enzymes and PCR amplification of genes, yielding plasmids pRPS415-wt and pRPS415-eng that 
were transformed into xylA-mutant E. coli HZE60.  L-Arabinose pathways consisted of two 
operons.  The first operon contained the xylose pathway (wild-type or engineered) as described 
above except that xylAp was replaced with the arabinose-inducible araBp promoter.  Operons 
were digested with NsiI and EcoRI, and ligated into pTrc99a.  The second operon contained 
LAD (wild-type LAD-wt or engineered LAD-3x), linker BA (see Chapter 4), and LXR under the 
araBp promoter.  These operons were digested with XbaI and EcoRI and ligated into pRSFDuet.  
Ligations were transformed into DH5, constructs were verified and plasmids were co-
transformed into araBAD-mutant E. coli HZE62. 
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